{"gene":"DDB2","run_date":"2026-06-09T23:54:41","timeline":{"discoveries":[{"year":2008,"finding":"Crystal structures of the DDB1-DDB2 complex alone and bound to DNA containing a 6-4PP lesion or abasic site revealed that the WD40 domain of DDB2 holds the lesion exclusively; a DDB2 hairpin inserts into the minor groove, extrudes the photodimer into a binding pocket, and kinks the duplex by ~40°, enabling DDB2 to detect lesions refractory to other surveillance proteins.","method":"X-ray crystallography with functional validation","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structures of multiple complexes with functional validation, single rigorous study with multiple substrates","pmids":["19109893"],"is_preprint":false},{"year":2003,"finding":"DDB2 and CSA are each integrated into nearly identical complexes via interaction with DDB1; both complexes contain cullin 4A and Roc1 and display E3 ubiquitin ligase activity; the COP9 signalosome (CSN) differentially regulates the ubiquitin ligase activity of the DDB2 and CSA complexes in response to UV irradiation; CSN knockdown by RNAi causes defects in NER.","method":"Co-immunoprecipitation, ubiquitin ligase activity assay, RNAi knockdown with NER functional readout","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, enzymatic activity assay, and RNAi phenotype in one study; widely cited and foundational","pmids":["12732143"],"is_preprint":false},{"year":2003,"finding":"In vivo, DDB2 (p48) localizes to UV-irradiated sites containing either CPDs or 6-4PPs; XPC localizes only to 6-4PP sites unless DDB2 is overexpressed, which then recruits XPC to CPD sites, demonstrating that DDB2 activates XPC recruitment to CPDs.","method":"Live-cell/fixed-cell immunofluorescence in repair-deficient XP-A cells expressing photolyases, overexpression of p48","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct localization experiment with functional consequence, photolyase-based lesion specificity control, replicated across labs","pmids":["12944386"],"is_preprint":false},{"year":2005,"finding":"Reconstituted DDB1-DDB2 complex binds UV-induced CPDs with ~6-fold higher affinity than undamaged DNA, binds 6-4PPs and abasic sites with high specificity, and also binds 2–3 bp mismatches; DDB1-DDB2 functions as a structural distortion sensor rather than a lesion-specific detector.","method":"In vitro reconstitution of DDB1-DDB2 with purified subunits; electrophoretic mobility shift assay with defined substrates","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified proteins and multiple defined DNA substrates","pmids":["16223728"],"is_preprint":false},{"year":2001,"finding":"Cullin 4A (CUL4A) is a specific E3 ubiquitin ligase targeting DDB2 for ubiquitination and proteasomal degradation; coexpression of CUL4A (but not Cul-1 or other related cullins) increases ubiquitination and decay rate of DDB2; a naturally occurring XP-E mutant of DDB2 (2RO) that does not bind CUL4A is unaffected.","method":"Coexpression, ubiquitination assay, proteasome inhibitor treatment, DDB2 mutant analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (coexpression, proteasome inhibitor, binding-defective mutant), replicated by subsequent studies","pmids":["11564859"],"is_preprint":false},{"year":2005,"finding":"Purified CUL4A-containing E3 complex directly ubiquitylates DDB2 in vitro; reconstitution confirmed that the DDB-CUL4A E3 complex is sufficient for DDB2 ubiquitylation.","method":"In vitro ubiquitylation assay with purified E3 complex","journal":"DNA repair","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with near-homogeneous purified components","pmids":["15811626"],"is_preprint":false},{"year":2006,"finding":"CUL4A mediates proteasomal degradation of DDB2 at UV-damage sites; blocking CUL4A (by siRNA or MG132) prolongs DDB2 retention at damage foci; CUL4A knockdown decreases XPC recruitment to damage sites and reduces CPD removal from the genome.","method":"siRNA knockdown, proteasome inhibitor, immunofluorescence at micropore-irradiated sites, CPD repair assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent inhibition approaches (siRNA + small molecule) with functional NER readout","pmids":["16527807"],"is_preprint":false},{"year":2002,"finding":"p53 directly binds and transcriptionally activates the human DDB2 gene via a p53-responsive element in the DDB2 promoter; the orthologous region in the mouse DDB2 gene does not support p53 binding or activation, explaining deficient UV-inducible DDB2 expression in mouse cells.","method":"p53 binding assay to DDB2 promoter sequences, transcriptional reporter assays, p53 protein accumulation vs. DDB2 mRNA in mouse cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct binding assay and transcriptional reporter in human and mouse cells with orthologous sequence comparison","pmids":["11971958"],"is_preprint":false},{"year":2012,"finding":"DDB2 facilitates poly(ADP-ribosyl)ation of UV-damaged chromatin via PARP1, leading to recruitment of the chromatin-remodeling enzyme ALC1; DDB2 itself is targeted by poly(ADP-ribosyl)ation, increasing its protein stability and prolonged chromatin retention by suppressing DDB2 ubiquitylation.","method":"Co-immunoprecipitation, in vitro and in vivo PAR assay, ALC1 depletion with UV sensitivity readout","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, in vitro/in vivo PAR assay, depletion phenotype) in one study","pmids":["23045548"],"is_preprint":false},{"year":2012,"finding":"DDB2 promotes large-scale chromatin decondensation at UV-induced lesions independently of the CRL4 ubiquitin ligase complex; this requires PARP1 activity; XPC lesion recognition (but not DDB2) requires ATP-dependent processes and is regulated by steady-state PAR levels.","method":"Fluorescence-based chromatin unfolding assay, DDB2-deficient cells, PARP1 inhibition, ATP depletion","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, DDB2-deficient cells as genetic control, distinct from ubiquitin ligase function","pmids":["22492724"],"is_preprint":false},{"year":2007,"finding":"In vivo, the majority of DDB2 diffuses in the nucleus as part of a high-molecular-mass complex; essentially all DDB2 binds UV-induced damage with ~2-minute residence time; DDB2 is proteolytically degraded with a half-life much longer than its residence time on a lesion, indicating that damaged-DNA binding is not the primary trigger for DDB2 degradation; DDB2 binding to/dissociation from lesions is independent of XPC.","method":"Fluorescence recovery after photobleaching (FRAP), live-cell imaging of fluorescently tagged DDB2, local UV irradiation","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Strong — FRAP and live imaging with multiple cell lines and quantitative kinetic analysis","pmids":["17635991"],"is_preprint":false},{"year":2014,"finding":"p97/VCP/Cdc48 segregase complex is required for timely removal of DDB2 and XPC from chromatin; prolonged retention due to p97 deficiency impairs DNA excision repair; chromosomal aberrations caused by excess chromatin-retained DDB2 are alleviated by concurrent DDB2 downregulation.","method":"p97 knockdown, DDB2/XPC knockdown epistasis, chromatin fractionation, NER assay, chromosomal aberration analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis (double knockdown rescue), multiple orthogonal readouts","pmids":["24770583"],"is_preprint":false},{"year":2020,"finding":"Timely DDB2 dissociation from UV lesions is required for DNA damage handover to XPC; DDB2 ubiquitylation promotes its dissociation/degradation to prevent excessive lesion re-binding; arrival of TFIIH further promotes DDB2 dissociation and formation of a stable XPC-TFIIH damage-verification complex.","method":"Live-cell imaging, ubiquitination assays, FRAP, genetic manipulation of DDB2 degradation","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods, mechanistic dissection of handover kinetics","pmids":["32985517"],"is_preprint":false},{"year":2020,"finding":"SIRT6 interacts with DDB2 (interaction enhanced upon UV), deacetylates DDB2 at K35 and K77 upon UV stress, thereby promoting DDB2 ubiquitination and segregation from chromatin to facilitate downstream NER signaling.","method":"Co-immunoprecipitation, in vitro deacetylation assay, mutagenesis of K35 and K77, chromatin fractionation, NER assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro deacetylation assay plus mutagenesis and chromatin fractionation in one study","pmids":["32789493"],"is_preprint":false},{"year":2014,"finding":"The N-terminal alanine of DDB2 (after Met removal) is trimethylated on its α-amino group by the N-terminal RCC1 methyltransferase; a methylation-defective DDB2 mutant shows diminished nuclear localization, reduced recruitment to CPD foci, compromised ATM activation, decreased CPD repair efficiency, and elevated UV sensitivity.","method":"Mass spectrometry, in vitro methylation assay, methylation-defective mutant expression, immunofluorescence at CPD foci, ATM activation and repair assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mass spectrometry identification, in vitro enzymatic assay, and multiple functional readouts from methylation-defective mutant","pmids":["24753253"],"is_preprint":false},{"year":2015,"finding":"The N-terminal tail of DDB2 (containing seven lysines) is the major site for CUL4-mediated ubiquitination targeting DDB2 for proteasomal degradation; XPC competitively suppresses DDB2 ubiquitination in vitro, an effect augmented by centrin-2; XPC thereby protects DDB2 from degradation, allowing multiple rounds of repair.","method":"Exogenous expression of mutant DDB2 in fibroblasts, in vitro ubiquitination competition assay, XPC/centrin-2 addition","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro reconstitution of competitive ubiquitination combined with cell-based mutant complementation","pmids":["25628365"],"is_preprint":false},{"year":2017,"finding":"DDB2 is SUMOylated at Lys-309 upon UV irradiation; SUMOylation depends on DDB2 binding to damaged chromatin and an active 26S proteasome; SUMO-1 conjugation is the major modification; K309R mutant DDB2 loses ability to recruit XPC to damage sites and to repair CPDs.","method":"In vitro and in vivo SUMOylation assay, K309R mutagenesis, XPC localization assay, CPD repair assay","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro SUMOylation assay and mutagenesis with multiple functional readouts","pmids":["28981631"],"is_preprint":false},{"year":2013,"finding":"DDB2 SUMOylation (by PIASy as major SUMO E3 ligase) is UV-dependent; PIASy knockdown reduces CPD removal from the genome but does not affect 6-4PP removal, indicating that PIASy-mediated DDB2 SUMOylation is specifically required for CPD repair.","method":"RNAi knockdown of PIASy, CPD and 6-4PP repair assays, Co-immunoprecipitation of DDB2-PIASy","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with specific repair readout and Co-IP, single lab","pmids":["23860269"],"is_preprint":false},{"year":2010,"finding":"The ubiquitin ligase activity of the DDB2 complex is required for efficient GG-NER in chromatin; XP-E patient-derived mutant DDB2 proteins fail to mediate ubiquitylation at damage sites; CSN dissociates from the DDB2 complex upon binding to damaged DNA; XPC and Ku oppositely regulate DDB2 complex ubiquitin ligase activity at damaged sites; DDB2 complex-mediated ubiquitylation recruits XPA to damaged sites.","method":"In vivo ubiquitination assay, mutant DDB2 complementation, chromatin fractionation, XPA recruitment assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches, XP-E patient-derived mutants as controls, XPA recruitment as functional readout","pmids":["20368362"],"is_preprint":false},{"year":2008,"finding":"p38 MAPK phosphorylates DDB2 and mediates UV-induced DDB2 ubiquitylation and degradation; p38 MAPK inhibition (SB203580) impairs DDB2 degradation, histone H3 acetylation/chromatin relaxation, XPC and TFIIH recruitment to UV-damage sites, and CPD repair.","method":"p38 MAPK inhibitor, phosphorylation assay, ubiquitination assay, chromatin relaxation assay, immunofluorescence recruitment assay, CPD repair","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods in one study, single lab","pmids":["18806262"],"is_preprint":false},{"year":2013,"finding":"DDB2 association with PCNA via a PIP-box in its N-terminal region is required for DDB2 proteasomal degradation after UV; mutation of the PIP-box or PCNA depletion by RNAi greatly impairs UV-induced DDB2 degradation; DDB2 co-localizes with PCNA and p21 at local UV-damage sites; p21 requires PCNA (not direct DDB2 binding) to form a trimeric complex with DDB2.","method":"PIP-box mutagenesis, PCNA RNAi, co-immunoprecipitation, in vitro binding assay with recombinant proteins, immunofluorescence","journal":"Cell cycle","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis + RNAi + in vitro binding with recombinant proteins, mechanistic detail on degradation pathway","pmids":["24200966"],"is_preprint":false},{"year":2006,"finding":"DDB1 is required for UV-induced DDB2 ubiquitylation and degradation; DDB1 knockdown impairs CUL4A translocation to UV-damaged chromatin but does not affect DDB2's intrinsic DNA damage-binding activity (DDB2 can bind damaged DNA as a monomer in vivo); DDB1 is critical for NER of CPDs but not 6-4PPs.","method":"DDB1 siRNA knockdown, chromatin fractionation, UV lesion repair assay, local UV irradiation foci analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — siRNA with multiple orthogonal readouts; monomer-binding claim supported by fractionation data","pmids":["16951172"],"is_preprint":false},{"year":2004,"finding":"UV radiation causes XPC translocation from loosely-bound to tightly chromatin-associated form; this redistribution requires both p53 and DDB2; ectopic DDB2 expression in p53-deficient cells rescues XPC translocation and recruitment to damage sites, placing DDB2 downstream of p53 in regulating XPC.","method":"Chromatin fractionation, immunofluorescence at local UV damage sites, ectopic DDB2 expression in p53-null cells","journal":"Carcinogenesis","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis by rescue experiment, two orthogonal methods","pmids":["14742321"],"is_preprint":false},{"year":2007,"finding":"DDB2 participates in NER by regulating cellular levels of p21(Waf1/Cip1): DDB2 enhances DDB1 nuclear accumulation, which targets phospho-Ser18-p53 for degradation, suppressing p21 expression; elevated p21 in DDB2-deficient MEFs causes NER deficiency, reversed by p21 deletion or knockdown; DDB2 thereby licenses NER by preventing PCNA sequestration by p21.","method":"DDB2-/- and p21-/- mouse embryonic fibroblasts (genetic epistasis), DDB1 fractionation, p21 knockdown rescue of NER, in vitro/in vivo NER assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double-mutant rescue, multiple independent readouts","pmids":["17967871"],"is_preprint":false},{"year":2009,"finding":"DDB2 targets p21(Waf1/Cip1) for proteasomal degradation via the CUL4A-DDB1 E3 ligase; this regulatory function of DDB2 defines the cell fate decision between apoptosis and cell cycle arrest after DNA damage; DDB2-deficient cells show increased p21, resist apoptosis (including E2F1-induced apoptosis), and undergo cell cycle arrest instead; Mdm2 is involved in DDB2-dependent apoptosis in a p53-independent manner.","method":"DDB2-deficient cell analysis, p21 proteolysis assay, DDB2 overexpression and knockdown, E2F1 apoptosis assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic and biochemical approaches, loss-of-function with specific apoptosis/arrest phenotype","pmids":["19541625"],"is_preprint":false},{"year":2003,"finding":"DDB2 directly regulates p53 levels before and after UV irradiation (via an intron 4 p53-binding element); XP-E cells are defective in UV-induced apoptosis due to severely reduced basal and UV-induced p53 levels; these defects are restored by DDB2 cDNA constructs containing intron 4, establishing mutual regulatory interactions between DDB2 and p53.","method":"DDB2 expression constructs (with/without intron 4), p53 protein level measurement, apoptosis assay in XP-E cells","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rescue by specific construct variant, single lab","pmids":["14560002"],"is_preprint":false},{"year":2002,"finding":"BRCA1 enhances p53 binding to the DDB2 promoter and p53-dependent transactivation of DDB2 promoter-reporter constructs; antisense BRCA1 abrogates UV-induced DDB2 upregulation; reduced BRCA1-dependent DDB2 function delays CPD and 6-4PP removal.","method":"Chromatin immunoprecipitation (p53 at DDB2 promoter), promoter-reporter assay, antisense BRCA1 knockdown, photoproduct repair assay","journal":"Cancer biology & therapy","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and reporter assay with antisense knockdown, single lab","pmids":["12170778"],"is_preprint":false},{"year":2012,"finding":"Deubiquitinating enzyme USP24 interacts with DDB2; USP24 knockdown decreases steady-state DDB2 levels; USP24 cleaves ubiquitinated DDB2 in vitro, indicating USP24 stabilizes DDB2 by preventing its ubiquitin-mediated degradation.","method":"Yeast two-hybrid, co-immunoprecipitation, USP24 knockdown, in vitro deubiquitination assay","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro deubiquitination assay plus co-IP and knockdown, single lab","pmids":["23159851"],"is_preprint":false},{"year":2021,"finding":"Deubiquitinase USP44 directly deubiquitinates DDB2 to prevent its premature degradation; USP44-deficient cells show impaired DDB2 accumulation at DNA lesions, reduced XPC retention, and defective CPD repair; Usp44-knockout mice are prone to UV- and DMBA-induced tumors.","method":"In vitro deubiquitination assay, USP44 knockout cells/mice, DDB2 accumulation at foci, CPD repair assay, tumor incidence","journal":"Frontiers in cell and developmental biology","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro enzymatic assay, KO cells with repair readout, and in vivo tumor model","pmids":["33937266"],"is_preprint":false},{"year":2013,"finding":"DDB2 and XPC are required for damage-specific ATR and ATM recruitment and phosphorylation at UV-damage sites; ATR and ATM physically interact with XPC; in DDB2-deficient cells, ATR/ATM recruitment and phosphorylation of their substrates (Chk1, Chk2, H2AX, BRCA1) are reduced; ATR/ATM deficiency does not affect DDB2 or XPC recruitment, placing DDB2/XPC upstream of checkpoint kinase activation.","method":"Co-immunoprecipitation of ATR/ATM with XPC, local UV irradiation immunofluorescence, DDB2/XPC knockdown, ATR/ATM-deficient cells","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP and epistasis by genetic deficiency, single lab","pmids":["23422745"],"is_preprint":false},{"year":2010,"finding":"DDB2 represses antioxidant genes by recruiting CUL4A and Suv39h and increasing histone H3K9 trimethylation at their promoters; DDB2-deficient cells fail to accumulate ROS and do not undergo premature senescence; DDB2 expression is itself induced by ROS, forming a positive feedback loop.","method":"DDB2-deficient cells, ChIP for H3K9me3 at antioxidant gene promoters, ROS measurement, senescence assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP with loss-of-function phenotype, single lab","pmids":["20351176"],"is_preprint":false},{"year":2013,"finding":"DDB2 constitutively represses EMT-regulatory genes in colon cancer cells; DDB2 depletion promotes mesenchymal phenotype while DDB2 re-expression restores epithelial phenotype; DDB2 inhibits EMT induced by hypoxia and TGF-β.","method":"DDB2 knockdown/overexpression with EMT marker analysis (qPCR, immunofluorescence), invasion assay, xenograft metastasis model","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple functional readouts with bidirectional genetic manipulation, single lab","pmids":["23610444"],"is_preprint":false},{"year":2013,"finding":"DDB2 decreases NF-κB activity by upregulating IκBα transcription through direct binding to the IκBα proximal promoter; this suppresses MMP9 expression and limits breast tumor cell invasiveness; knockdown of DDB2-induced IκBα restores NF-κB activity and invasive properties.","method":"DDB2 overexpression/knockdown, promoter binding assay (ChIP), invasion assay, NF-κB activity reporter, IκBα rescue experiment","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and rescue experiment, single lab","pmids":["23774208"],"is_preprint":false},{"year":2015,"finding":"DDB2 binds the NEDD4L promoter and recruits EZH2 to repress NEDD4L transcription by enhancing H3K27me3 at the NEDD4L promoter; repression of NEDD4L by DDB2 enhances TGF-β signal transduction in ovarian cancer cells.","method":"ChIP for DDB2 and H3K27me3 at NEDD4L promoter, EZH2 co-immunoprecipitation, TGF-β signaling assays, DDB2 knockdown/overexpression","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP with functional TGF-β readout, single lab","pmids":["26130719"],"is_preprint":false},{"year":2017,"finding":"DDB2 recruits EZH2 and β-catenin to an upstream site in the Rnf43 gene, enabling interaction with distant TCF4/β-catenin binding sites in the Rnf43 intron to activate RNF43 expression, which restricts Wnt signaling; DDB2-deficient mice show increased susceptibility to colon tumor development with elevated Wnt pathway activation.","method":"ChIP for DDB2/EZH2/β-catenin at Rnf43 locus, DDB2-knockout mice, Wnt reporter assays, tumor incidence","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and in vivo knockout model with Wnt pathway readout, single lab","pmids":["29021137"],"is_preprint":false},{"year":2020,"finding":"EZH2 forms a complex with DDB1-DDB2 and stabilizes DDB2 by impairing its ubiquitination independently of its methyltransferase activity and PRC2 complex; EZH2 depletion reduces DDB2 localization to CPD crosslinks and impairs their repair; this activity is epistatic with DDB1-DDB2 for cisplatin sensitivity.","method":"Co-immunoprecipitation, ubiquitination assay, EZH2 depletion with DDB2 stability readout, synthetic lethality screen, CPD immunofluorescence, epistasis","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, and epistasis, single lab","pmids":["32457468"],"is_preprint":false},{"year":2015,"finding":"DDB2 interacts with the androgen receptor (AR), mediates contact between AR and the CUL4A-DDB1 complex, and promotes AR ubiquitination and proteasomal degradation; DNA damage-induced DDB2 expression reduces AR protein levels via this mechanism; DDB2 inhibits growth of AR-expressing prostate cancer cells (LNCaP) but not AR-null cells (PC3).","method":"Co-immunoprecipitation, ubiquitination assay, DDB2 overexpression in prostate cancer cell lines, cell growth assay","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ubiquitination assay with functional cell-growth readout, single lab","pmids":["22846800"],"is_preprint":false},{"year":2019,"finding":"DDB2 directly interacts with LRH-1 (liver receptor homologue-1) and functions as the substrate recognition component of CUL4-DDB1 to promote LRH-1 ubiquitination and proteasomal degradation; DDB2 overexpression reduces insulin-stimulated LRH-1 levels and decreases glucokinase expression; DDB2 knockdown increases glucose uptake and intracellular glucose-6-phosphate.","method":"Co-immunoprecipitation, ubiquitination assay, DDB2 overexpression/knockdown, gene expression and glucose metabolism assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, and metabolic readout, single lab","pmids":["30923324"],"is_preprint":false},{"year":2015,"finding":"DDB2 is involved in ubiquitination and degradation of PAQR3; DDB2 interacts with PAQR3 in vivo and in vitro; DDB2 controls PAQR3 protein stability and polyubiquitination; Lys-61 of PAQR3 is the target site; DDB2 knockdown decreases cancer cell proliferation and migration in a PAQR3-dependent manner.","method":"Co-immunoprecipitation, in vitro interaction assay, ubiquitination assay, Lys-61 mutation, DDB2/PAQR3 double knockdown epistasis","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding, ubiquitination assay, and site-specific mutagenesis plus epistasis, single lab","pmids":["26205499"],"is_preprint":false},{"year":2021,"finding":"CRL4-DDB2 is a novel E3 ubiquitin ligase for CDT2; DDB2 overexpression enhances CDT2 ubiquitination and degradation via a PIP-box-independent mechanism; DDB2 knockdown stabilizes CDT2 and arrests the cell cycle in G1; this pathway indirectly regulates CDT1 stability and pre-replication complex assembly.","method":"Co-immunoprecipitation, in vivo ubiquitination assay, DDB2 knockdown/overexpression, PIP-box mutant, cell cycle analysis","journal":"Cell & bioscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitination assay, mutagenesis, and cell cycle readout, single lab","pmids":["33557942"],"is_preprint":false},{"year":2016,"finding":"UVRAG localizes to photolesions, associates with DDB1, and promotes assembly and activity of the DDB2-DDB1-CUL4A-ROC1 (CRL4-DDB2) ubiquitin ligase complex, leading to efficient XPC recruitment and global genome NER; UVRAG depletion decreases substrate handover to XPC.","method":"Co-immunoprecipitation of UVRAG with DDB1, local UV irradiation immunofluorescence, UVRAG depletion with NER and XPC recruitment readout, Drosophila genetic model","journal":"Molecular cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and localization assay with NER functional readout, confirmed in Drosophila model","pmids":["27203177"],"is_preprint":false},{"year":2006,"finding":"Claspin physically associates with DDB1 and DDB2 and is required for UV-induced DDB2 degradation and co-localization of DDB2 to damage sites; Claspin knockdown abolishes UV-induced DDB2 turnover at damage foci but does not affect XPC levels or XPC co-localization with lesions.","method":"Claspin siRNA knockdown, DDB2 degradation assay, immunofluorescence co-localization, co-immunoprecipitation","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with multiple readouts and Co-IP, single lab","pmids":["17196446"],"is_preprint":false},{"year":2016,"finding":"DDB2 associates with XRCC5/6 (Ku70/Ku80) in a CUL4-independent and DNA-PKcs-independent manner; in the absence of DNA damage, chromatin association of XRCC5 requires DDB2; DDB2 recruits XRCC5 to the SEMA3A gene promoter to activate its transcription; XRCC5 depletion inhibits SEMA3A expression without affecting VEGFA (a DDB2-repressed gene).","method":"Co-immunoprecipitation, chromatin fractionation, DDB2 knockdown with XRCC5 localization readout, ChIP at SEMA3A promoter","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, and loss-of-function localization assay, single lab","pmids":["28035050"],"is_preprint":false},{"year":2021,"finding":"MEKK1 kinase constitutively interacts with a cytosolic CRL4 complex and is cleaved by caspases after DNA damage; MEKK1 kinase activity triggers autoubiquitination of the CRL4 complex; MEKK1 knockdown prevents DNA damage-induced degradation of DDB2 and p21; K63-linked ubiquitin chains contribute to DDB2/p21 decay and cell survival.","method":"Co-immunoprecipitation, ubiquitin-linkage replacement strategy, MEKK1 knockdown, DDB2 degradation assay, cell survival assay","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ubiquitin replacement, and knockdown with degradation readout, single lab","pmids":["34251884"],"is_preprint":false},{"year":2018,"finding":"DDB2 binds to the ALDH1A1 gene promoter, facilitates H3K27me3 enrichment at this region, and competes with the transcription factor C/EBPβ for binding, thereby repressing ALDH1A1 transcription and suppressing cancer stem cell dedifferentiation in ovarian cancer cells.","method":"ChIP for DDB2 and H3K27me3 at ALDH1A1 promoter, DDB2/C/EBPβ competition assay, DDB2 overexpression/knockdown with ALDH1A1 expression and CSC phenotype readout","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and competition assay with functional CSC readout, single lab","pmids":["29752431"],"is_preprint":false},{"year":2019,"finding":"DDB2 binds to an upstream promoter element in the HIF1A gene and recruits Suv39h1 to promote H3K9me3, repressing HIF1α mRNA expression in both normoxia and hypoxia; DDB2 knockdown enhances angiogenic marker expression and promotes xenograft tumor growth.","method":"ChIP for DDB2 and H3K9me3 at HIF1A promoter, DDB2 knockdown with HIF1α mRNA and angiogenic marker readout, xenograft tumor growth","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and loss-of-function with in vivo readout, single lab","pmids":["31740787"],"is_preprint":false},{"year":2004,"finding":"Four DDB2 splicing variants (D1-D4) were identified in HeLa cells; D1 and D2 act as dominant negative inhibitors of DNA repair; D1/D2 are not part of the damaged DNA-protein complex (EMSA); DDB2-WT interacts with D1 via co-immunoprecipitation; D1 expression reduces DDB1 nuclear import.","method":"RT-PCR, EMSA, DNA repair assay, co-immunoprecipitation, nuclear import assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple methods establishing dominant negative mechanism, single lab","pmids":["14751237"],"is_preprint":false},{"year":2001,"finding":"DDB2 is required for nuclear accumulation of DDB1; DDB2 C-terminal deletion mutants that fail to bind DDB1 can still associate with HBx and enhance nuclear accumulation of HBx independently of DDB1 binding, revealing a DDB1-independent DDB2 function in nuclear import.","method":"DDB2 deletion mutant expression, co-immunoprecipitation, nuclear localization assay","journal":"Journal of virology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — deletion mutant series with nuclear localization readout, single lab","pmids":["11581406"],"is_preprint":false},{"year":2008,"finding":"DDB2 levels in the cell critically determine the amount of DDB1 temporally immobilized on UV-damaged DNA; DDB2 (not CUL4A) is indispensable for DDB1 binding to damage sites; UV-induced DDB2 proteolysis releases DDB1 from continuous association with unrepaired DNA.","method":"FRAP of fluorescently tagged DDB1, DDB2 knockdown/overexpression, local UV irradiation","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — FRAP with genetic manipulation of DDB2 levels, single lab","pmids":["18936169"],"is_preprint":false},{"year":2000,"finding":"Both DDB1 and DDB2 subunits must be present for UV-damaged DNA binding activity; XP-E patient-derived DDB2 mutations (L350P, ΔN349, others) abolish DDB activity when expressed in insect cells; wild-type p48 (DDB2) restores DDB activity to XP-E cell-free extracts; these mutations do not affect nuclear localization of p48.","method":"Baculovirus overexpression of individual subunits, EMSA with UV-damaged DNA, complementation of XP-E extracts","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical reconstitution with individual subunits and patient-derived mutants, functional complementation","pmids":["10777490"],"is_preprint":false}],"current_model":"DDB2 (XPE/p48) is the substrate-recognition subunit of the CRL4(DDB2) E3 ubiquitin ligase complex that directly binds UV-induced photolesions (6-4PPs and CPDs) via its WD40 domain using a hairpin-insertion/extrusion mechanism; it opens chromatin at damage sites through PARP1-ALC1, recruits XPC for NER handover (regulated by competitive ubiquitination, deubiquitination by USP24/USP44, and post-translational modifications including poly-ADP-ribosylation, α-N-methylation, and SUMOylation), and also functions as a transcriptional regulator that represses EMT drivers, antioxidant genes, HIF1A, and ALDH1A1 while activating IκBα and RNF43, and controls cell fate after DNA damage by targeting p21 and p53 for CUL4A-mediated degradation."},"narrative":{"mechanistic_narrative":"DDB2 (XPE/p48) is the DNA-damage-recognition subunit of the CRL4(DDB2) E3 ubiquitin ligase that initiates global-genome nucleotide excision repair (GG-NER) of UV photolesions [PMID:19109893, PMID:20368362]. Its WD40 domain binds the lesion directly, inserting a hairpin into the minor groove to extrude the photodimer into a binding pocket and kink the duplex, enabling detection of helix-distorting lesions including CPDs, 6-4PPs, abasic sites, and mismatches that other surveillance proteins miss [PMID:19109893, PMID:16223728]. Both DDB1 and DDB2 subunits are required for damaged-DNA binding, and XP-E patient mutations abolish this activity [PMID:10777490]. Within the complex DDB2 partners with DDB1, CUL4A, and Roc1 to form an active E3 ligase whose output is gated by the COP9 signalosome [PMID:12732143]. DDB2 opens chromatin at damage sites by promoting PARP1-dependent poly(ADP-ribosyl)ation and recruitment of the remodeler ALC1, a chromatin-decondensation function separable from its ligase activity [PMID:23045548, PMID:22492724], and it then hands the lesion to XPC—DDB2 being required to recruit XPC and downstream factors (XPA) to CPD sites [PMID:12944386, PMID:20368362, PMID:14742321]. Productive handover requires timely DDB2 turnover: CUL4A-mediated ubiquitylation of the DDB2 N-terminal tail drives its dissociation and proteasomal degradation, with p97/VCP segregating it from chromatin and TFIIH arrival stabilizing the XPC-TFIIH verification complex [PMID:11564859, PMID:32985517, PMID:25628365, PMID:24770583]. This turnover is tuned by a dense regulatory layer—XPC/centrin-2 competitive protection [PMID:25628365], SIRT6 deacetylation [PMID:32789493], PARsylation, α-N-methylation, SUMOylation by PIASy [PMID:23045548, PMID:24753253, PMID:28981631, PMID:23860269], and deubiquitination by USP24 and USP44 [PMID:23159851, PMID:33937266]. Beyond repair, DDB2 expression is induced by p53 [PMID:11971958], and DDB2 in turn directs CRL4 to degrade p21 and modulate p53, governing the apoptosis-versus-arrest cell-fate decision after DNA damage [PMID:17967871, PMID:19541625]. DDB2 also acts as a chromatin-associated transcriptional regulator, repressing antioxidant genes, EMT drivers, HIF1A, and ALDH1A1 through recruitment of Suv39h/EZH2 and repressive histone methylation, while activating IκBα and RNF43 [PMID:20351176, PMID:23610444, PMID:29752431, PMID:31740787, PMID:29021137, PMID:23774208]. Inactivating DDB2 mutations underlie the xeroderma pigmentosum complementation group E (XP-E) defect in UV-damaged DNA binding and repair [PMID:10777490].","teleology":[{"year":2000,"claim":"Established that DDB2 is the subunit responsible for UV-damaged DNA binding and that its loss explains the XP-E repair defect, defining DDB2's core biochemical identity.","evidence":"Baculovirus reconstitution of individual subunits, EMSA with UV-damaged DNA, and complementation of XP-E extracts with patient-derived mutants","pmids":["10777490"],"confidence":"High","gaps":["Did not resolve how the lesion is physically engaged","Did not define the larger E3 ligase context"]},{"year":2001,"claim":"Identified CUL4A as the E3 that targets DDB2 for proteasomal degradation and showed DDB2 controls DDB1 nuclear accumulation, linking DDB2 turnover and localization to the cullin machinery.","evidence":"Coexpression, ubiquitination assays, proteasome inhibition, binding-defective XP-E mutant, and deletion-mutant nuclear localization assays","pmids":["11564859","11581406"],"confidence":"High","gaps":["Functional purpose of DDB2 degradation during repair not yet defined","DDB1-independent nuclear import role characterized only via HBx"]},{"year":2002,"claim":"Showed DDB2 is a transcriptional target of p53 (with BRCA1 enhancement), placing DDB2 induction within the DNA-damage response and explaining species differences in UV-inducible expression.","evidence":"p53 promoter-binding and reporter assays, ChIP, antisense BRCA1 knockdown, and human/mouse orthologous sequence comparison","pmids":["11971958","12170778"],"confidence":"High","gaps":["BRCA1 contribution from single lab","Did not address reciprocal DDB2 regulation of p53"]},{"year":2003,"claim":"Defined DDB2 as the substrate-recognition subunit of a CUL4A-Roc1-DDB1 E3 ligase regulated by the COP9 signalosome, and showed DDB2 activates XPC recruitment to CPD lesions in cells.","evidence":"Reciprocal Co-IP, ubiquitin ligase activity assays, CSN RNAi with NER readout, and immunofluorescence in photolyase-expressing XP cells; plus DDB2-p53 mutual regulation in XP-E cells","pmids":["12732143","12944386","14560002"],"confidence":"High","gaps":["Relevant in vivo ubiquitylation substrates at lesions not yet identified","p53 reciprocal regulation supported by single lab"]},{"year":2004,"claim":"Placed DDB2 downstream of p53 in driving the UV-induced chromatin redistribution of XPC, and identified dominant-negative splice variants, clarifying the DDB2-to-XPC handoff hierarchy.","evidence":"Chromatin fractionation, ectopic DDB2 rescue in p53-null cells, and RT-PCR/EMSA characterization of splice variants","pmids":["14742321","14751237"],"confidence":"High","gaps":["Molecular basis of XPC redistribution not yet defined","Physiological abundance of dominant-negative variants unknown"]},{"year":2005,"claim":"Reconstituted DDB2's lesion recognition as a structural-distortion sensor and confirmed the purified CUL4A E3 directly ubiquitylates DDB2, separating sensing from enzymatic output.","evidence":"In vitro reconstitution with purified subunits, EMSA across defined substrates, and in vitro ubiquitylation with purified E3","pmids":["16223728","15811626"],"confidence":"High","gaps":["Specificity for genuine photolesions vs. mismatches in chromatin not resolved","Functional consequence of auto-ubiquitylation not addressed here"]},{"year":2006,"claim":"Demonstrated that CUL4A/DDB1-mediated DDB2 degradation at damage sites is required for XPC recruitment and CPD removal, and that DDB1 is needed for CUL4A translocation but not for DDB2's intrinsic DNA binding.","evidence":"siRNA and MG132 inhibition, chromatin fractionation, micropore-irradiation immunofluorescence, CPD repair assays, plus Claspin Co-IP/knockdown","pmids":["16527807","16951172","17196446"],"confidence":"High","gaps":["Why degradation aids handover rather than ending recognition not yet mechanistically resolved","Claspin role from single lab"]},{"year":2007,"claim":"Quantified DDB2 lesion-binding kinetics and showed DDB2 licenses NER by degrading p53/limiting p21, preventing p21-mediated PCNA sequestration, linking DDB2 turnover to repair competence.","evidence":"FRAP and live-cell imaging of tagged DDB2; DDB2-/- and p21-/- MEF epistasis with NER assays","pmids":["17635991","17967871"],"confidence":"High","gaps":["Trigger coupling lesion residence to degradation not identified","p53/p21 axis tested in mouse cells"]},{"year":2008,"claim":"Provided the atomic mechanism of lesion recognition (hairpin insertion/extrusion, duplex kinking) and identified p38 MAPK as an upstream signal driving DDB2 ubiquitylation, chromatin relaxation, and repair.","evidence":"X-ray crystallography of DDB1-DDB2-DNA complexes with functional validation; p38 inhibitor with phosphorylation, ubiquitination, and CPD repair readouts; FRAP of DDB1 controlled by DDB2 levels","pmids":["19109893","18806262","18936169"],"confidence":"High","gaps":["p38 phosphosite on DDB2 not mapped (Medium-confidence study)","Structural model from purified components without chromatin context"]},{"year":2010,"claim":"Showed the ligase activity is required for chromatin GG-NER and recruits XPA, with XPC/Ku oppositely tuning activity; and revealed a transcriptional repressor role at antioxidant genes via Suv39h/H3K9me3.","evidence":"In vivo ubiquitination with XP-E mutant complementation, chromatin fractionation, XPA recruitment; and ChIP/ROS/senescence assays in DDB2-deficient cells","pmids":["20368362","20351176"],"confidence":"High","gaps":["Histone substrates of the ligase at lesions not fully defined","Antioxidant-gene repression from single lab (Medium)"]},{"year":2012,"claim":"Separated DDB2's PARP1/ALC1-driven large-scale chromatin decondensation from its ligase activity, and identified PARsylation, USP24 deubiquitination, and a p21-degradation cell-fate function as regulators of DDB2 stability and outcome.","evidence":"Chromatin-unfolding assays in DDB2-deficient cells with PARP inhibition; Co-IP/PAR assays/ALC1 depletion; USP24 yeast two-hybrid and in vitro deubiquitination; DDB2-deficient apoptosis/arrest analysis","pmids":["22492724","23045548","23159851","19541625"],"confidence":"High","gaps":["How decondensation and ligase functions are coordinated unclear","USP24 and p21 cell-fate findings from single labs (Medium)"]},{"year":2013,"claim":"Expanded DDB2's regulatory repertoire to PIASy-mediated SUMOylation for CPD repair, PCNA-PIP-box-coupled degradation, checkpoint kinase (ATR/ATM) activation, and transcriptional control of EMT, NF-κB/IκBα, and NEDD4L/TGF-β.","evidence":"PIASy RNAi with lesion-specific repair; PIP-box mutagenesis and PCNA RNAi; ATR/ATM Co-IP and DDB2/XPC knockdown; EMT and IκBα/NF-κB and NEDD4L/EZH2 ChIP and functional assays","pmids":["23860269","24200966","23422745","23610444","23774208","26130719"],"confidence":"Medium","gaps":["Each regulatory and transcriptional arm rests on a single lab","Direct vs. indirect transcriptional targeting not always resolved"]},{"year":2014,"claim":"Identified non-degradative DDB2 modifications and cofactors—α-N-trimethylation, p97/VCP segregase extraction—that govern its localization, recruitment, ATM activation, and timely chromatin removal.","evidence":"Mass spectrometry and in vitro methylation with methylation-defective mutant; p97 knockdown with DDB2/XPC epistasis, chromatin fractionation, and chromosomal aberration analysis","pmids":["24753253","24770583"],"confidence":"High","gaps":["Interplay between methylation and ubiquitination not resolved","Functional importance of α-N-methylation tested in one system"]},{"year":2015,"claim":"Defined the DDB2 N-terminal lysine tail as the major ubiquitination site under XPC/centrin-2 competitive protection, and extended CRL4(DDB2) substrate range to AR, PAQR3, and TGF-β regulators.","evidence":"DDB2 N-terminal mutants, in vitro competitive ubiquitination with XPC/centrin-2; Co-IP and ubiquitination assays for AR (prostate cells) and PAQR3 (epistasis), plus NEDD4L transcriptional work","pmids":["25628365","22846800","26205499"],"confidence":"Medium","gaps":["Substrate-targeting findings (AR, PAQR3) each from a single lab","Physiological selectivity among the many proposed substrates unclear"]},{"year":2017,"claim":"Established SUMOylation at K309 as essential for XPC recruitment and CPD repair, and identified a CUL4-independent DDB2-Ku (XRCC5/6) axis driving SEMA3A transcription.","evidence":"In vitro/in vivo SUMOylation with K309R mutant and repair readout; Co-IP, chromatin fractionation, and ChIP at the SEMA3A promoter","pmids":["28981631","28035050"],"confidence":"Medium","gaps":["Both findings from single labs","Relationship between SUMOylation and ubiquitination/degradation timing unresolved"]},{"year":2019,"claim":"Broadened DDB2's transcriptional and substrate roles to HIF1A repression via Suv39h1/H3K9me3 and CRL4-mediated LRH-1 degradation affecting glucose metabolism.","evidence":"ChIP for DDB2/H3K9me3 at HIF1A with xenograft readout; Co-IP, ubiquitination, and glucose-metabolism assays for LRH-1","pmids":["31740787","30923324"],"confidence":"Medium","gaps":["Each role from a single lab","Direct vs. indirect mechanism for metabolic effects not fully dissected"]},{"year":2020,"claim":"Resolved the kinetic logic of repair handover—ubiquitylation-driven DDB2 dissociation enabling XPC-TFIIH verification—and added SIRT6 deacetylation and EZH2 stabilization as upstream controls of DDB2 retention.","evidence":"Live-cell imaging, FRAP, and ubiquitination manipulation; SIRT6 Co-IP/deacetylation with K35/K77 mutants; EZH2 Co-IP, ubiquitination, and cisplatin-sensitivity epistasis","pmids":["32985517","32789493","32457468"],"confidence":"High","gaps":["SIRT6 and EZH2 contributions from single labs (Medium)","Quantitative ordering of all modifications at a single lesion not established"]},{"year":2021,"claim":"Identified additional turnover regulators (USP44 deubiquitination, MEKK1-driven CRL4 autoubiquitination) and a new substrate (CDT2 linking DDB2 to replication licensing), extending its DNA-damage and cell-cycle roles.","evidence":"In vitro deubiquitination and USP44 KO cells/mice with tumor incidence; MEKK1 Co-IP and ubiquitin-linkage replacement; CDT2 Co-IP, ubiquitination, PIP-box mutant, and cell-cycle analysis","pmids":["33937266","34251884","33557942"],"confidence":"Medium","gaps":["MEKK1 and CDT2 findings from single labs","Integration of K63-linked chains into DDB2 fate not fully resolved"]},{"year":null,"claim":"How DDB2's dual repair-ligase and transcriptional-regulator activities are coordinated, and which of its many proposed CRL4 substrates and transcriptional targets are physiologically dominant in a given tissue, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model relating chromatin opening, ubiquitylation, and transcriptional repression","Many substrate/target relationships rest on single-lab evidence","Tissue-specific selectivity of substrate engagement unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,3,49]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,5,18,24]},{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[1,5]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[30,32,34,44,45]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,18]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[30,44,45]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,47,49]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[2,9,11,22]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[10,48]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,2,18,49]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,4,5,24]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[30,31,32,34,44,45]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[8,9,30,44,45]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[24]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[7,19,29]}],"complexes":["CRL4(DDB2) (DDB1-DDB2-CUL4A-Roc1) E3 ubiquitin ligase","DDB1-DDB2 (UV-DDB) complex"],"partners":["DDB1","CUL4A","XPC","PARP1","EZH2","USP44","SIRT6","PCNA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q92466","full_name":"DNA damage-binding protein 2","aliases":["DDB p48 subunit","DDBb","Damage-specific DNA-binding protein 2","UV-damaged DNA-binding protein 2","UV-DDB 2"],"length_aa":427,"mass_kda":47.9,"function":"Protein, which is both involved in DNA repair and protein ubiquitination, as part of the UV-DDB complex and DCX (DDB1-CUL4-X-box) complexes, respectively (PubMed:10882109, PubMed:11278856, PubMed:11705987, PubMed:12732143, PubMed:15882621, PubMed:16473935, PubMed:18593899, PubMed:32789493, PubMed:9892649). Core component of the UV-DDB complex (UV-damaged DNA-binding protein complex), a complex that recognizes UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair (PubMed:10882109, PubMed:11278856, PubMed:11705987, PubMed:12944386, PubMed:14751237, PubMed:16260596, PubMed:32789493). The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches (PubMed:10882109, PubMed:11278856, PubMed:11705987, PubMed:12944386, PubMed:16260596). Also functions as the substrate recognition module for the DCX (DDB2-CUL4-X-box) E3 ubiquitin-protein ligase complex DDB2-CUL4-ROC1 (also known as CUL4-DDB-ROC1 and CUL4-DDB-RBX1) (PubMed:12732143, PubMed:15882621, PubMed:16473935, PubMed:18593899, PubMed:26572825). The DDB2-CUL4-ROC1 complex may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage (PubMed:16473935, PubMed:16678110). The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair (PubMed:16473935, PubMed:16678110). The DDB2-CUL4-ROC1 complex also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER (PubMed:15882621). The DDB2-CUL4-ROC1 complex also ubiquitinates KAT7/HBO1 in response to DNA damage, leading to its degradation: recognizes KAT7/HBO1 following phosphorylation by ATR (PubMed:26572825) Inhibits UV-damaged DNA repair Inhibits UV-damaged DNA repair","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q92466/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DDB2","classification":"Not Classified","n_dependent_lines":5,"n_total_lines":1208,"dependency_fraction":0.0041390728476821195},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DDB1","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DDB2","total_profiled":1310},"omim":[{"mim_id":"613208","title":"XPC COMPLEX SUBUNIT, DNA DAMAGE RECOGNITION AND REPAIR FACTOR; XPC","url":"https://www.omim.org/entry/613208"},{"mim_id":"610898","title":"SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3","url":"https://www.omim.org/entry/610898"},{"mim_id":"609412","title":"ERCC EXCISION REPAIR 8, CSA UBIQUITIN LIGASE COMPLEX SUBUNIT; ERCC8","url":"https://www.omim.org/entry/609412"},{"mim_id":"607999","title":"ASH1-LIKE HISTONE LYSINE METHYLTRANSFERASE; ASH1L","url":"https://www.omim.org/entry/607999"},{"mim_id":"603137","title":"CULLIN 4A; CUL4A","url":"https://www.omim.org/entry/603137"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cell Junctions","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DDB2"},"hgnc":{"alias_symbol":["DDBB","UV-DDB2","FLJ34321","XPE"],"prev_symbol":[]},"alphafold":{"accession":"Q92466","domains":[{"cath_id":"-","chopping":"70-99","consensus_level":"medium","plddt":90.3457,"start":70,"end":99},{"cath_id":"2.130.10.10","chopping":"104-419","consensus_level":"high","plddt":92.7956,"start":104,"end":419}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92466","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q92466-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q92466-F1-predicted_aligned_error_v6.png","plddt_mean":83.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DDB2","jax_strain_url":"https://www.jax.org/strain/search?query=DDB2"},"sequence":{"accession":"Q92466","fasta_url":"https://rest.uniprot.org/uniprotkb/Q92466.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q92466/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q92466"}},"corpus_meta":[{"pmid":"12732143","id":"PMC_12732143","title":"The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage.","date":"2003","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12732143","citation_count":604,"is_preprint":false},{"pmid":"19109893","id":"PMC_19109893","title":"Structural basis of UV DNA-damage recognition by the DDB1-DDB2 complex.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/19109893","citation_count":353,"is_preprint":false},{"pmid":"23045548","id":"PMC_23045548","title":"PARP1 promotes nucleotide excision repair through DDB2 stabilization and recruitment of ALC1.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/23045548","citation_count":214,"is_preprint":false},{"pmid":"12944386","id":"PMC_12944386","title":"In vivo recruitment of XPC to UV-induced cyclobutane pyrimidine dimers by the DDB2 gene product.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12944386","citation_count":198,"is_preprint":false},{"pmid":"8407968","id":"PMC_8407968","title":"Comparative analysis of binding of human damaged DNA-binding protein (XPE) and Escherichia coli damage recognition protein (UvrA) to the major ultraviolet photoproducts: T[c,s]T, T[t,s]T, T[6-4]T, and T[Dewar]T.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8407968","citation_count":175,"is_preprint":false},{"pmid":"11564859","id":"PMC_11564859","title":"The xeroderma pigmentosum group E gene product DDB2 is a specific target of cullin 4A in mammalian cells.","date":"2001","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11564859","citation_count":140,"is_preprint":false},{"pmid":"8530102","id":"PMC_8530102","title":"Chromosomal localization and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8530102","citation_count":135,"is_preprint":false},{"pmid":"11971958","id":"PMC_11971958","title":"p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11971958","citation_count":134,"is_preprint":false},{"pmid":"16527807","id":"PMC_16527807","title":"Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16527807","citation_count":129,"is_preprint":false},{"pmid":"16223728","id":"PMC_16223728","title":"DDB1-DDB2 (xeroderma pigmentosum group E) protein complex recognizes a cyclobutane pyrimidine dimer, mismatches, apurinic/apyrimidinic sites, and compound lesions in DNA.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16223728","citation_count":129,"is_preprint":false},{"pmid":"22492724","id":"PMC_22492724","title":"DDB2 promotes chromatin decondensation at UV-induced DNA damage.","date":"2012","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22492724","citation_count":121,"is_preprint":false},{"pmid":"10777490","id":"PMC_10777490","title":"Human damage-specific DNA-binding protein p48. Characterization of XPE mutations and regulation following UV irradiation.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10777490","citation_count":116,"is_preprint":false},{"pmid":"24770583","id":"PMC_24770583","title":"Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24770583","citation_count":97,"is_preprint":false},{"pmid":"18089819","id":"PMC_18089819","title":"Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.","date":"2007","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/18089819","citation_count":96,"is_preprint":false},{"pmid":"17635991","id":"PMC_17635991","title":"Dynamic in vivo interaction of DDB2 E3 ubiquitin ligase with UV-damaged DNA is independent of damage-recognition protein XPC.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17635991","citation_count":91,"is_preprint":false},{"pmid":"14742321","id":"PMC_14742321","title":"UV radiation-induced XPC translocation within chromatin is mediated by damaged-DNA binding protein, DDB2.","date":"2004","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/14742321","citation_count":91,"is_preprint":false},{"pmid":"12812979","id":"PMC_12812979","title":"True XP group E patients have a defective UV-damaged DNA binding protein complex and mutations in DDB2 which reveal the functional domains of its p48 product.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12812979","citation_count":90,"is_preprint":false},{"pmid":"16951172","id":"PMC_16951172","title":"DNA damage binding protein component DDB1 participates in nucleotide excision repair through DDB2 DNA-binding and cullin 4A ubiquitin ligase activity.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16951172","citation_count":85,"is_preprint":false},{"pmid":"14769931","id":"PMC_14769931","title":"DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14769931","citation_count":78,"is_preprint":false},{"pmid":"19541625","id":"PMC_19541625","title":"DDB2 decides cell fate following DNA damage.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19541625","citation_count":75,"is_preprint":false},{"pmid":"12826282","id":"PMC_12826282","title":"The DDB2 nucleotide excision repair gene product p48 enhances global genomic repair in p53 deficient human fibroblasts.","date":"2003","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/12826282","citation_count":75,"is_preprint":false},{"pmid":"15558025","id":"PMC_15558025","title":"Tumor-prone phenotype of the DDB2-deficient mice.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15558025","citation_count":74,"is_preprint":false},{"pmid":"12170778","id":"PMC_12170778","title":"BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation.","date":"2002","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/12170778","citation_count":70,"is_preprint":false},{"pmid":"16288018","id":"PMC_16288018","title":"Enhanced DDB2 expression protects mice from carcinogenic effects of chronic UV-B irradiation.","date":"2005","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16288018","citation_count":68,"is_preprint":false},{"pmid":"23604128","id":"PMC_23604128","title":"Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23604128","citation_count":68,"is_preprint":false},{"pmid":"14560002","id":"PMC_14560002","title":"Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/14560002","citation_count":63,"is_preprint":false},{"pmid":"23422745","id":"PMC_23422745","title":"NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites.","date":"2013","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/23422745","citation_count":59,"is_preprint":false},{"pmid":"15811626","id":"PMC_15811626","title":"DDB2, the xeroderma pigmentosum group E gene product, is directly ubiquitylated by Cullin 4A-based ubiquitin ligase complex.","date":"2005","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/15811626","citation_count":59,"is_preprint":false},{"pmid":"23610444","id":"PMC_23610444","title":"DDB2 suppresses epithelial-to-mesenchymal transition in colon cancer.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23610444","citation_count":56,"is_preprint":false},{"pmid":"12151405","id":"PMC_12151405","title":"Hepatitis B virus X protein associated with UV-DDB1 induces cell death in the nucleus and is functionally antagonized by UV-DDB2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12151405","citation_count":56,"is_preprint":false},{"pmid":"32985517","id":"PMC_32985517","title":"Ubiquitin and TFIIH-stimulated DDB2 dissociation drives DNA damage handover in nucleotide excision repair.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32985517","citation_count":53,"is_preprint":false},{"pmid":"32789493","id":"PMC_32789493","title":"The deacetylase SIRT6 promotes the repair of UV-induced DNA damage by targeting DDB2.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32789493","citation_count":53,"is_preprint":false},{"pmid":"20013802","id":"PMC_20013802","title":"Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.","date":"2010","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/20013802","citation_count":53,"is_preprint":false},{"pmid":"24753253","id":"PMC_24753253","title":"α-N-methylation of damaged DNA-binding protein 2 (DDB2) and its function in nucleotide excision repair.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24753253","citation_count":50,"is_preprint":false},{"pmid":"19923893","id":"PMC_19923893","title":"DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response.","date":"2009","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/19923893","citation_count":49,"is_preprint":false},{"pmid":"20368362","id":"PMC_20368362","title":"DDB2 complex-mediated ubiquitylation around DNA damage is oppositely regulated by XPC and Ku and contributes to the recruitment of XPA.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20368362","citation_count":49,"is_preprint":false},{"pmid":"10469312","id":"PMC_10469312","title":"A newly identified patient with clinical xeroderma pigmentosum phenotype has a non-sense mutation in the DDB2 gene and incomplete repair in (6-4) photoproducts.","date":"1999","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/10469312","citation_count":49,"is_preprint":false},{"pmid":"18806262","id":"PMC_18806262","title":"The p38 mitogen-activated protein kinase augments nucleotide excision repair by mediating DDB2 degradation and chromatin relaxation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18806262","citation_count":46,"is_preprint":false},{"pmid":"16260596","id":"PMC_16260596","title":"Xeroderma pigmentosum complementation group E protein (XPE/DDB2): purification of various complexes of XPE and analyses of their damaged DNA binding and putative DNA repair properties.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16260596","citation_count":45,"is_preprint":false},{"pmid":"25628365","id":"PMC_25628365","title":"Functional regulation of the DNA damage-recognition factor DDB2 by ubiquitination and interaction with xeroderma pigmentosum group C protein.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25628365","citation_count":45,"is_preprint":false},{"pmid":"26130719","id":"PMC_26130719","title":"DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26130719","citation_count":45,"is_preprint":false},{"pmid":"32457468","id":"PMC_32457468","title":"EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32457468","citation_count":43,"is_preprint":false},{"pmid":"17967871","id":"PMC_17967871","title":"The xeroderma pigmentosum group E gene product DDB2 activates nucleotide excision repair by regulating the level of p21Waf1/Cip1.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17967871","citation_count":43,"is_preprint":false},{"pmid":"23159851","id":"PMC_23159851","title":"The deubiquitinating protein USP24 interacts with DDB2 and regulates DDB2 stability.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23159851","citation_count":41,"is_preprint":false},{"pmid":"24574518","id":"PMC_24574518","title":"DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.","date":"2014","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/24574518","citation_count":41,"is_preprint":false},{"pmid":"23774208","id":"PMC_23774208","title":"DDB2: a novel regulator of NF-κB and breast tumor invasion.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23774208","citation_count":40,"is_preprint":false},{"pmid":"12527763","id":"PMC_12527763","title":"Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12527763","citation_count":39,"is_preprint":false},{"pmid":"11581406","id":"PMC_11581406","title":"DDB2 induces nuclear accumulation of the hepatitis B virus X protein independently of binding to DDB1.","date":"2001","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/11581406","citation_count":38,"is_preprint":false},{"pmid":"27203177","id":"PMC_27203177","title":"Autophagic UVRAG Promotes UV-Induced Photolesion Repair by Activation of the CRL4(DDB2) E3 Ligase.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27203177","citation_count":36,"is_preprint":false},{"pmid":"31635251","id":"PMC_31635251","title":"Emerging Roles of DDB2 in Cancer.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31635251","citation_count":33,"is_preprint":false},{"pmid":"20351176","id":"PMC_20351176","title":"DDB2, an essential mediator of premature senescence.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20351176","citation_count":33,"is_preprint":false},{"pmid":"22336944","id":"PMC_22336944","title":"MC1R variant allele effects on UVR-induced phosphorylation of p38, p53, and DDB2 repair protein responses in melanocytic cells in culture.","date":"2012","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/22336944","citation_count":32,"is_preprint":false},{"pmid":"15644494","id":"PMC_15644494","title":"Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP.","date":"2005","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15644494","citation_count":32,"is_preprint":false},{"pmid":"18936169","id":"PMC_18936169","title":"Cellular concentrations of DDB2 regulate dynamic binding of DDB1 at UV-induced DNA damage.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18936169","citation_count":31,"is_preprint":false},{"pmid":"17468495","id":"PMC_17468495","title":"Ddb2 is a haploinsufficient tumor suppressor and controls spontaneous germ cell apoptosis.","date":"2007","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17468495","citation_count":30,"is_preprint":false},{"pmid":"29752431","id":"PMC_29752431","title":"DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/29752431","citation_count":29,"is_preprint":false},{"pmid":"20509621","id":"PMC_20509621","title":"Antimony impairs nucleotide excision repair: XPA and XPE as potential molecular targets.","date":"2010","source":"Chemical research in toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/20509621","citation_count":29,"is_preprint":false},{"pmid":"22167187","id":"PMC_22167187","title":"p21 cooperates with DDB2 protein in suppression of ultraviolet ray-induced skin malignancies.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22167187","citation_count":28,"is_preprint":false},{"pmid":"28212551","id":"PMC_28212551","title":"NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28212551","citation_count":26,"is_preprint":false},{"pmid":"17173070","id":"PMC_17173070","title":"E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17173070","citation_count":26,"is_preprint":false},{"pmid":"26205499","id":"PMC_26205499","title":"DDB2 is involved in ubiquitination and degradation of PAQR3 and regulates tumorigenesis of gastric cancer cells.","date":"2015","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/26205499","citation_count":25,"is_preprint":false},{"pmid":"29021137","id":"PMC_29021137","title":"DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29021137","citation_count":25,"is_preprint":false},{"pmid":"10713455","id":"PMC_10713455","title":"Studies of the murine DDB1 and DDB2 genes.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10713455","citation_count":25,"is_preprint":false},{"pmid":"35813480","id":"PMC_35813480","title":"Hypoxia-inducible CircPFKFB4 Promotes Breast Cancer Progression by Facilitating the CRL4DDB2 E3 Ubiquitin Ligase-mediated p27 Degradation.","date":"2022","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35813480","citation_count":23,"is_preprint":false},{"pmid":"16550608","id":"PMC_16550608","title":"Evaluation of xeroderma pigmentosum XPA, XPC, XPD, XPF, XPB, XPG and DDB2 genes in familial early-onset lung cancer predisposition.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16550608","citation_count":22,"is_preprint":false},{"pmid":"30410671","id":"PMC_30410671","title":"DDB2 regulates Epithelial-to-Mesenchymal Transition (EMT) in Oral/Head and Neck Squamous Cell Carcinoma.","date":"2018","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/30410671","citation_count":20,"is_preprint":false},{"pmid":"22846800","id":"PMC_22846800","title":"DDB2 is a novel AR interacting protein and mediates AR ubiquitination/degradation.","date":"2012","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22846800","citation_count":20,"is_preprint":false},{"pmid":"24200966","id":"PMC_24200966","title":"DDB2 association with PCNA is required for its degradation after UV-induced DNA damage.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24200966","citation_count":19,"is_preprint":false},{"pmid":"16522664","id":"PMC_16522664","title":"Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study.","date":"2006","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/16522664","citation_count":19,"is_preprint":false},{"pmid":"34589276","id":"PMC_34589276","title":"ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions.","date":"2021","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/34589276","citation_count":18,"is_preprint":false},{"pmid":"17196446","id":"PMC_17196446","title":"Role of Claspin in regulation of nucleotide excision repair factor DDB2.","date":"2006","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/17196446","citation_count":18,"is_preprint":false},{"pmid":"28981631","id":"PMC_28981631","title":"UV radiation-induced SUMOylation of DDB2 regulates nucleotide excision repair.","date":"2017","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/28981631","citation_count":16,"is_preprint":false},{"pmid":"14751237","id":"PMC_14751237","title":"Human DDB2 splicing variants are dominant negative inhibitors of UV-damaged DNA repair.","date":"2004","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14751237","citation_count":16,"is_preprint":false},{"pmid":"29169765","id":"PMC_29169765","title":"Whole Exome Sequencing allows the identification of two novel groups of Xeroderma pigmentosum in Tunisia, XP-D and XP-E: Impact on molecular diagnosis.","date":"2017","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/29169765","citation_count":16,"is_preprint":false},{"pmid":"31740787","id":"PMC_31740787","title":"NER-factor DDB2 regulates HIF1α and hypoxia-response genes in HNSCC.","date":"2019","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31740787","citation_count":15,"is_preprint":false},{"pmid":"33557942","id":"PMC_33557942","title":"DDB2 regulates DNA replication through PCNA-independent degradation of CDT2.","date":"2021","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/33557942","citation_count":15,"is_preprint":false},{"pmid":"27553023","id":"PMC_27553023","title":"DDB2 increases radioresistance of NSCLC cells by enhancing DNA damage responses.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27553023","citation_count":15,"is_preprint":false},{"pmid":"35428778","id":"PMC_35428778","title":"Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35428778","citation_count":15,"is_preprint":false},{"pmid":"16325378","id":"PMC_16325378","title":"Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.","date":"2005","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/16325378","citation_count":15,"is_preprint":false},{"pmid":"30923324","id":"PMC_30923324","title":"Regulation of liver receptor homologue-1 by DDB2 E3 ligase activity is critical for hepatic glucose metabolism.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30923324","citation_count":14,"is_preprint":false},{"pmid":"24335308","id":"PMC_24335308","title":"A novel DDB2-ATM feedback loop regulates human cytomegalovirus replication.","date":"2013","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/24335308","citation_count":13,"is_preprint":false},{"pmid":"29078035","id":"PMC_29078035","title":"Dual control of ROS1-mediated active DNA demethylation by DNA damage-binding protein 2 (DDB2).","date":"2017","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29078035","citation_count":13,"is_preprint":false},{"pmid":"26263968","id":"PMC_26263968","title":"Combination of Aβ Secretion and Oxidative Stress in an Alzheimer-Like Cell Line Leads to the Over-Expression of the Nucleotide Excision Repair Proteins DDB2 and XPC.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26263968","citation_count":13,"is_preprint":false},{"pmid":"23114715","id":"PMC_23114715","title":"Tumor regression by phenethyl isothiocyanate involves DDB2.","date":"2012","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/23114715","citation_count":13,"is_preprint":false},{"pmid":"11852074","id":"PMC_11852074","title":"Restoration of UV sensitivity in UV-resistant HeLa cells by antisense-mediated depletion of damaged DNA-binding protein 2 (DDB2).","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11852074","citation_count":12,"is_preprint":false},{"pmid":"21388382","id":"PMC_21388382","title":"Nucleotide excision repair proteins rapidly accumulate but fail to persist in human XP-E (DDB2 mutant) cells.","date":"2011","source":"Photochemistry and photobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21388382","citation_count":12,"is_preprint":false},{"pmid":"36568213","id":"PMC_36568213","title":"DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy.","date":"2022","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36568213","citation_count":11,"is_preprint":false},{"pmid":"24260342","id":"PMC_24260342","title":"Coordination between p21 and DDB2 in the cellular response to UV radiation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24260342","citation_count":11,"is_preprint":false},{"pmid":"33937266","id":"PMC_33937266","title":"USP44 Stabilizes DDB2 to Facilitate Nucleotide Excision Repair and Prevent Tumors.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33937266","citation_count":11,"is_preprint":false},{"pmid":"26879405","id":"PMC_26879405","title":"DDB2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells.","date":"2016","source":"Nanoscale","url":"https://pubmed.ncbi.nlm.nih.gov/26879405","citation_count":11,"is_preprint":false},{"pmid":"26187069","id":"PMC_26187069","title":"The 5'-UTR of DDB2 harbors an IRES element and upregulates translation during stress conditions.","date":"2015","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/26187069","citation_count":11,"is_preprint":false},{"pmid":"37142578","id":"PMC_37142578","title":"MBD2 facilitates tumor metastasis by mitigating DDB2 expression.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37142578","citation_count":10,"is_preprint":false},{"pmid":"23860269","id":"PMC_23860269","title":"SUMOylation of damaged DNA-binding protein DDB2.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23860269","citation_count":10,"is_preprint":false},{"pmid":"28035050","id":"PMC_28035050","title":"Chromatin association of XRCC5/6 in the absence of DNA damage depends on the XPE gene product DDB2.","date":"2016","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/28035050","citation_count":10,"is_preprint":false},{"pmid":"17630510","id":"PMC_17630510","title":"DDB2-independent role for p53 in the recovery from ultraviolet light-induced replication arrest.","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17630510","citation_count":10,"is_preprint":false},{"pmid":"25573302","id":"PMC_25573302","title":"Variants in SELL, MRPS36P2, TP63, DDB2, CACNA1H, ADAM19, GNAI1, CDH13 and GABRG2 interact to confer risk of acne in Chinese population.","date":"2015","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25573302","citation_count":10,"is_preprint":false},{"pmid":"24489677","id":"PMC_24489677","title":"Monitoring repair of UV-induced 6-4-photoproducts with a purified DDB2 protein complex.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24489677","citation_count":9,"is_preprint":false},{"pmid":"21117171","id":"PMC_21117171","title":"Detection of bulky DNA lesions: DDB2 at the interface of chromatin and DNA repair in eukaryotes.","date":"2010","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/21117171","citation_count":9,"is_preprint":false},{"pmid":"34251884","id":"PMC_34251884","title":"MEKK1-Dependent Activation of the CRL4 Complex Is Important for DNA Damage-Induced Degradation of p21 and DDB2 and Cell Survival.","date":"2021","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/34251884","citation_count":9,"is_preprint":false},{"pmid":"33544716","id":"PMC_33544716","title":"Regulation of ddb2 expression in blind cavefish and zebrafish reveals plasticity in the control of sunlight-induced DNA damage repair.","date":"2021","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33544716","citation_count":9,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47124,"output_tokens":11901,"usd":0.159943,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23018,"output_tokens":6863,"usd":0.143333,"stage2_stop_reason":"end_turn"},"total_usd":0.303276,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structures of the DDB1-DDB2 complex alone and bound to DNA containing a 6-4PP lesion or abasic site revealed that the WD40 domain of DDB2 holds the lesion exclusively; a DDB2 hairpin inserts into the minor groove, extrudes the photodimer into a binding pocket, and kinks the duplex by ~40°, enabling DDB2 to detect lesions refractory to other surveillance proteins.\",\n      \"method\": \"X-ray crystallography with functional validation\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structures of multiple complexes with functional validation, single rigorous study with multiple substrates\",\n      \"pmids\": [\"19109893\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DDB2 and CSA are each integrated into nearly identical complexes via interaction with DDB1; both complexes contain cullin 4A and Roc1 and display E3 ubiquitin ligase activity; the COP9 signalosome (CSN) differentially regulates the ubiquitin ligase activity of the DDB2 and CSA complexes in response to UV irradiation; CSN knockdown by RNAi causes defects in NER.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin ligase activity assay, RNAi knockdown with NER functional readout\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, enzymatic activity assay, and RNAi phenotype in one study; widely cited and foundational\",\n      \"pmids\": [\"12732143\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In vivo, DDB2 (p48) localizes to UV-irradiated sites containing either CPDs or 6-4PPs; XPC localizes only to 6-4PP sites unless DDB2 is overexpressed, which then recruits XPC to CPD sites, demonstrating that DDB2 activates XPC recruitment to CPDs.\",\n      \"method\": \"Live-cell/fixed-cell immunofluorescence in repair-deficient XP-A cells expressing photolyases, overexpression of p48\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct localization experiment with functional consequence, photolyase-based lesion specificity control, replicated across labs\",\n      \"pmids\": [\"12944386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Reconstituted DDB1-DDB2 complex binds UV-induced CPDs with ~6-fold higher affinity than undamaged DNA, binds 6-4PPs and abasic sites with high specificity, and also binds 2–3 bp mismatches; DDB1-DDB2 functions as a structural distortion sensor rather than a lesion-specific detector.\",\n      \"method\": \"In vitro reconstitution of DDB1-DDB2 with purified subunits; electrophoretic mobility shift assay with defined substrates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified proteins and multiple defined DNA substrates\",\n      \"pmids\": [\"16223728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Cullin 4A (CUL4A) is a specific E3 ubiquitin ligase targeting DDB2 for ubiquitination and proteasomal degradation; coexpression of CUL4A (but not Cul-1 or other related cullins) increases ubiquitination and decay rate of DDB2; a naturally occurring XP-E mutant of DDB2 (2RO) that does not bind CUL4A is unaffected.\",\n      \"method\": \"Coexpression, ubiquitination assay, proteasome inhibitor treatment, DDB2 mutant analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (coexpression, proteasome inhibitor, binding-defective mutant), replicated by subsequent studies\",\n      \"pmids\": [\"11564859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Purified CUL4A-containing E3 complex directly ubiquitylates DDB2 in vitro; reconstitution confirmed that the DDB-CUL4A E3 complex is sufficient for DDB2 ubiquitylation.\",\n      \"method\": \"In vitro ubiquitylation assay with purified E3 complex\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with near-homogeneous purified components\",\n      \"pmids\": [\"15811626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CUL4A mediates proteasomal degradation of DDB2 at UV-damage sites; blocking CUL4A (by siRNA or MG132) prolongs DDB2 retention at damage foci; CUL4A knockdown decreases XPC recruitment to damage sites and reduces CPD removal from the genome.\",\n      \"method\": \"siRNA knockdown, proteasome inhibitor, immunofluorescence at micropore-irradiated sites, CPD repair assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent inhibition approaches (siRNA + small molecule) with functional NER readout\",\n      \"pmids\": [\"16527807\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p53 directly binds and transcriptionally activates the human DDB2 gene via a p53-responsive element in the DDB2 promoter; the orthologous region in the mouse DDB2 gene does not support p53 binding or activation, explaining deficient UV-inducible DDB2 expression in mouse cells.\",\n      \"method\": \"p53 binding assay to DDB2 promoter sequences, transcriptional reporter assays, p53 protein accumulation vs. DDB2 mRNA in mouse cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct binding assay and transcriptional reporter in human and mouse cells with orthologous sequence comparison\",\n      \"pmids\": [\"11971958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DDB2 facilitates poly(ADP-ribosyl)ation of UV-damaged chromatin via PARP1, leading to recruitment of the chromatin-remodeling enzyme ALC1; DDB2 itself is targeted by poly(ADP-ribosyl)ation, increasing its protein stability and prolonged chromatin retention by suppressing DDB2 ubiquitylation.\",\n      \"method\": \"Co-immunoprecipitation, in vitro and in vivo PAR assay, ALC1 depletion with UV sensitivity readout\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, in vitro/in vivo PAR assay, depletion phenotype) in one study\",\n      \"pmids\": [\"23045548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DDB2 promotes large-scale chromatin decondensation at UV-induced lesions independently of the CRL4 ubiquitin ligase complex; this requires PARP1 activity; XPC lesion recognition (but not DDB2) requires ATP-dependent processes and is regulated by steady-state PAR levels.\",\n      \"method\": \"Fluorescence-based chromatin unfolding assay, DDB2-deficient cells, PARP1 inhibition, ATP depletion\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, DDB2-deficient cells as genetic control, distinct from ubiquitin ligase function\",\n      \"pmids\": [\"22492724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In vivo, the majority of DDB2 diffuses in the nucleus as part of a high-molecular-mass complex; essentially all DDB2 binds UV-induced damage with ~2-minute residence time; DDB2 is proteolytically degraded with a half-life much longer than its residence time on a lesion, indicating that damaged-DNA binding is not the primary trigger for DDB2 degradation; DDB2 binding to/dissociation from lesions is independent of XPC.\",\n      \"method\": \"Fluorescence recovery after photobleaching (FRAP), live-cell imaging of fluorescently tagged DDB2, local UV irradiation\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — FRAP and live imaging with multiple cell lines and quantitative kinetic analysis\",\n      \"pmids\": [\"17635991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"p97/VCP/Cdc48 segregase complex is required for timely removal of DDB2 and XPC from chromatin; prolonged retention due to p97 deficiency impairs DNA excision repair; chromosomal aberrations caused by excess chromatin-retained DDB2 are alleviated by concurrent DDB2 downregulation.\",\n      \"method\": \"p97 knockdown, DDB2/XPC knockdown epistasis, chromatin fractionation, NER assay, chromosomal aberration analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis (double knockdown rescue), multiple orthogonal readouts\",\n      \"pmids\": [\"24770583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Timely DDB2 dissociation from UV lesions is required for DNA damage handover to XPC; DDB2 ubiquitylation promotes its dissociation/degradation to prevent excessive lesion re-binding; arrival of TFIIH further promotes DDB2 dissociation and formation of a stable XPC-TFIIH damage-verification complex.\",\n      \"method\": \"Live-cell imaging, ubiquitination assays, FRAP, genetic manipulation of DDB2 degradation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods, mechanistic dissection of handover kinetics\",\n      \"pmids\": [\"32985517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SIRT6 interacts with DDB2 (interaction enhanced upon UV), deacetylates DDB2 at K35 and K77 upon UV stress, thereby promoting DDB2 ubiquitination and segregation from chromatin to facilitate downstream NER signaling.\",\n      \"method\": \"Co-immunoprecipitation, in vitro deacetylation assay, mutagenesis of K35 and K77, chromatin fractionation, NER assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro deacetylation assay plus mutagenesis and chromatin fractionation in one study\",\n      \"pmids\": [\"32789493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The N-terminal alanine of DDB2 (after Met removal) is trimethylated on its α-amino group by the N-terminal RCC1 methyltransferase; a methylation-defective DDB2 mutant shows diminished nuclear localization, reduced recruitment to CPD foci, compromised ATM activation, decreased CPD repair efficiency, and elevated UV sensitivity.\",\n      \"method\": \"Mass spectrometry, in vitro methylation assay, methylation-defective mutant expression, immunofluorescence at CPD foci, ATM activation and repair assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mass spectrometry identification, in vitro enzymatic assay, and multiple functional readouts from methylation-defective mutant\",\n      \"pmids\": [\"24753253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The N-terminal tail of DDB2 (containing seven lysines) is the major site for CUL4-mediated ubiquitination targeting DDB2 for proteasomal degradation; XPC competitively suppresses DDB2 ubiquitination in vitro, an effect augmented by centrin-2; XPC thereby protects DDB2 from degradation, allowing multiple rounds of repair.\",\n      \"method\": \"Exogenous expression of mutant DDB2 in fibroblasts, in vitro ubiquitination competition assay, XPC/centrin-2 addition\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro reconstitution of competitive ubiquitination combined with cell-based mutant complementation\",\n      \"pmids\": [\"25628365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DDB2 is SUMOylated at Lys-309 upon UV irradiation; SUMOylation depends on DDB2 binding to damaged chromatin and an active 26S proteasome; SUMO-1 conjugation is the major modification; K309R mutant DDB2 loses ability to recruit XPC to damage sites and to repair CPDs.\",\n      \"method\": \"In vitro and in vivo SUMOylation assay, K309R mutagenesis, XPC localization assay, CPD repair assay\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro SUMOylation assay and mutagenesis with multiple functional readouts\",\n      \"pmids\": [\"28981631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DDB2 SUMOylation (by PIASy as major SUMO E3 ligase) is UV-dependent; PIASy knockdown reduces CPD removal from the genome but does not affect 6-4PP removal, indicating that PIASy-mediated DDB2 SUMOylation is specifically required for CPD repair.\",\n      \"method\": \"RNAi knockdown of PIASy, CPD and 6-4PP repair assays, Co-immunoprecipitation of DDB2-PIASy\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with specific repair readout and Co-IP, single lab\",\n      \"pmids\": [\"23860269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The ubiquitin ligase activity of the DDB2 complex is required for efficient GG-NER in chromatin; XP-E patient-derived mutant DDB2 proteins fail to mediate ubiquitylation at damage sites; CSN dissociates from the DDB2 complex upon binding to damaged DNA; XPC and Ku oppositely regulate DDB2 complex ubiquitin ligase activity at damaged sites; DDB2 complex-mediated ubiquitylation recruits XPA to damaged sites.\",\n      \"method\": \"In vivo ubiquitination assay, mutant DDB2 complementation, chromatin fractionation, XPA recruitment assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches, XP-E patient-derived mutants as controls, XPA recruitment as functional readout\",\n      \"pmids\": [\"20368362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"p38 MAPK phosphorylates DDB2 and mediates UV-induced DDB2 ubiquitylation and degradation; p38 MAPK inhibition (SB203580) impairs DDB2 degradation, histone H3 acetylation/chromatin relaxation, XPC and TFIIH recruitment to UV-damage sites, and CPD repair.\",\n      \"method\": \"p38 MAPK inhibitor, phosphorylation assay, ubiquitination assay, chromatin relaxation assay, immunofluorescence recruitment assay, CPD repair\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods in one study, single lab\",\n      \"pmids\": [\"18806262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DDB2 association with PCNA via a PIP-box in its N-terminal region is required for DDB2 proteasomal degradation after UV; mutation of the PIP-box or PCNA depletion by RNAi greatly impairs UV-induced DDB2 degradation; DDB2 co-localizes with PCNA and p21 at local UV-damage sites; p21 requires PCNA (not direct DDB2 binding) to form a trimeric complex with DDB2.\",\n      \"method\": \"PIP-box mutagenesis, PCNA RNAi, co-immunoprecipitation, in vitro binding assay with recombinant proteins, immunofluorescence\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis + RNAi + in vitro binding with recombinant proteins, mechanistic detail on degradation pathway\",\n      \"pmids\": [\"24200966\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DDB1 is required for UV-induced DDB2 ubiquitylation and degradation; DDB1 knockdown impairs CUL4A translocation to UV-damaged chromatin but does not affect DDB2's intrinsic DNA damage-binding activity (DDB2 can bind damaged DNA as a monomer in vivo); DDB1 is critical for NER of CPDs but not 6-4PPs.\",\n      \"method\": \"DDB1 siRNA knockdown, chromatin fractionation, UV lesion repair assay, local UV irradiation foci analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — siRNA with multiple orthogonal readouts; monomer-binding claim supported by fractionation data\",\n      \"pmids\": [\"16951172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"UV radiation causes XPC translocation from loosely-bound to tightly chromatin-associated form; this redistribution requires both p53 and DDB2; ectopic DDB2 expression in p53-deficient cells rescues XPC translocation and recruitment to damage sites, placing DDB2 downstream of p53 in regulating XPC.\",\n      \"method\": \"Chromatin fractionation, immunofluorescence at local UV damage sites, ectopic DDB2 expression in p53-null cells\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis by rescue experiment, two orthogonal methods\",\n      \"pmids\": [\"14742321\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"DDB2 participates in NER by regulating cellular levels of p21(Waf1/Cip1): DDB2 enhances DDB1 nuclear accumulation, which targets phospho-Ser18-p53 for degradation, suppressing p21 expression; elevated p21 in DDB2-deficient MEFs causes NER deficiency, reversed by p21 deletion or knockdown; DDB2 thereby licenses NER by preventing PCNA sequestration by p21.\",\n      \"method\": \"DDB2-/- and p21-/- mouse embryonic fibroblasts (genetic epistasis), DDB1 fractionation, p21 knockdown rescue of NER, in vitro/in vivo NER assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double-mutant rescue, multiple independent readouts\",\n      \"pmids\": [\"17967871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"DDB2 targets p21(Waf1/Cip1) for proteasomal degradation via the CUL4A-DDB1 E3 ligase; this regulatory function of DDB2 defines the cell fate decision between apoptosis and cell cycle arrest after DNA damage; DDB2-deficient cells show increased p21, resist apoptosis (including E2F1-induced apoptosis), and undergo cell cycle arrest instead; Mdm2 is involved in DDB2-dependent apoptosis in a p53-independent manner.\",\n      \"method\": \"DDB2-deficient cell analysis, p21 proteolysis assay, DDB2 overexpression and knockdown, E2F1 apoptosis assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic and biochemical approaches, loss-of-function with specific apoptosis/arrest phenotype\",\n      \"pmids\": [\"19541625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"DDB2 directly regulates p53 levels before and after UV irradiation (via an intron 4 p53-binding element); XP-E cells are defective in UV-induced apoptosis due to severely reduced basal and UV-induced p53 levels; these defects are restored by DDB2 cDNA constructs containing intron 4, establishing mutual regulatory interactions between DDB2 and p53.\",\n      \"method\": \"DDB2 expression constructs (with/without intron 4), p53 protein level measurement, apoptosis assay in XP-E cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rescue by specific construct variant, single lab\",\n      \"pmids\": [\"14560002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"BRCA1 enhances p53 binding to the DDB2 promoter and p53-dependent transactivation of DDB2 promoter-reporter constructs; antisense BRCA1 abrogates UV-induced DDB2 upregulation; reduced BRCA1-dependent DDB2 function delays CPD and 6-4PP removal.\",\n      \"method\": \"Chromatin immunoprecipitation (p53 at DDB2 promoter), promoter-reporter assay, antisense BRCA1 knockdown, photoproduct repair assay\",\n      \"journal\": \"Cancer biology & therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and reporter assay with antisense knockdown, single lab\",\n      \"pmids\": [\"12170778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Deubiquitinating enzyme USP24 interacts with DDB2; USP24 knockdown decreases steady-state DDB2 levels; USP24 cleaves ubiquitinated DDB2 in vitro, indicating USP24 stabilizes DDB2 by preventing its ubiquitin-mediated degradation.\",\n      \"method\": \"Yeast two-hybrid, co-immunoprecipitation, USP24 knockdown, in vitro deubiquitination assay\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro deubiquitination assay plus co-IP and knockdown, single lab\",\n      \"pmids\": [\"23159851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Deubiquitinase USP44 directly deubiquitinates DDB2 to prevent its premature degradation; USP44-deficient cells show impaired DDB2 accumulation at DNA lesions, reduced XPC retention, and defective CPD repair; Usp44-knockout mice are prone to UV- and DMBA-induced tumors.\",\n      \"method\": \"In vitro deubiquitination assay, USP44 knockout cells/mice, DDB2 accumulation at foci, CPD repair assay, tumor incidence\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro enzymatic assay, KO cells with repair readout, and in vivo tumor model\",\n      \"pmids\": [\"33937266\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DDB2 and XPC are required for damage-specific ATR and ATM recruitment and phosphorylation at UV-damage sites; ATR and ATM physically interact with XPC; in DDB2-deficient cells, ATR/ATM recruitment and phosphorylation of their substrates (Chk1, Chk2, H2AX, BRCA1) are reduced; ATR/ATM deficiency does not affect DDB2 or XPC recruitment, placing DDB2/XPC upstream of checkpoint kinase activation.\",\n      \"method\": \"Co-immunoprecipitation of ATR/ATM with XPC, local UV irradiation immunofluorescence, DDB2/XPC knockdown, ATR/ATM-deficient cells\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP and epistasis by genetic deficiency, single lab\",\n      \"pmids\": [\"23422745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DDB2 represses antioxidant genes by recruiting CUL4A and Suv39h and increasing histone H3K9 trimethylation at their promoters; DDB2-deficient cells fail to accumulate ROS and do not undergo premature senescence; DDB2 expression is itself induced by ROS, forming a positive feedback loop.\",\n      \"method\": \"DDB2-deficient cells, ChIP for H3K9me3 at antioxidant gene promoters, ROS measurement, senescence assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with loss-of-function phenotype, single lab\",\n      \"pmids\": [\"20351176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DDB2 constitutively represses EMT-regulatory genes in colon cancer cells; DDB2 depletion promotes mesenchymal phenotype while DDB2 re-expression restores epithelial phenotype; DDB2 inhibits EMT induced by hypoxia and TGF-β.\",\n      \"method\": \"DDB2 knockdown/overexpression with EMT marker analysis (qPCR, immunofluorescence), invasion assay, xenograft metastasis model\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple functional readouts with bidirectional genetic manipulation, single lab\",\n      \"pmids\": [\"23610444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DDB2 decreases NF-κB activity by upregulating IκBα transcription through direct binding to the IκBα proximal promoter; this suppresses MMP9 expression and limits breast tumor cell invasiveness; knockdown of DDB2-induced IκBα restores NF-κB activity and invasive properties.\",\n      \"method\": \"DDB2 overexpression/knockdown, promoter binding assay (ChIP), invasion assay, NF-κB activity reporter, IκBα rescue experiment\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and rescue experiment, single lab\",\n      \"pmids\": [\"23774208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DDB2 binds the NEDD4L promoter and recruits EZH2 to repress NEDD4L transcription by enhancing H3K27me3 at the NEDD4L promoter; repression of NEDD4L by DDB2 enhances TGF-β signal transduction in ovarian cancer cells.\",\n      \"method\": \"ChIP for DDB2 and H3K27me3 at NEDD4L promoter, EZH2 co-immunoprecipitation, TGF-β signaling assays, DDB2 knockdown/overexpression\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP with functional TGF-β readout, single lab\",\n      \"pmids\": [\"26130719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DDB2 recruits EZH2 and β-catenin to an upstream site in the Rnf43 gene, enabling interaction with distant TCF4/β-catenin binding sites in the Rnf43 intron to activate RNF43 expression, which restricts Wnt signaling; DDB2-deficient mice show increased susceptibility to colon tumor development with elevated Wnt pathway activation.\",\n      \"method\": \"ChIP for DDB2/EZH2/β-catenin at Rnf43 locus, DDB2-knockout mice, Wnt reporter assays, tumor incidence\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and in vivo knockout model with Wnt pathway readout, single lab\",\n      \"pmids\": [\"29021137\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"EZH2 forms a complex with DDB1-DDB2 and stabilizes DDB2 by impairing its ubiquitination independently of its methyltransferase activity and PRC2 complex; EZH2 depletion reduces DDB2 localization to CPD crosslinks and impairs their repair; this activity is epistatic with DDB1-DDB2 for cisplatin sensitivity.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, EZH2 depletion with DDB2 stability readout, synthetic lethality screen, CPD immunofluorescence, epistasis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, and epistasis, single lab\",\n      \"pmids\": [\"32457468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DDB2 interacts with the androgen receptor (AR), mediates contact between AR and the CUL4A-DDB1 complex, and promotes AR ubiquitination and proteasomal degradation; DNA damage-induced DDB2 expression reduces AR protein levels via this mechanism; DDB2 inhibits growth of AR-expressing prostate cancer cells (LNCaP) but not AR-null cells (PC3).\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, DDB2 overexpression in prostate cancer cell lines, cell growth assay\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ubiquitination assay with functional cell-growth readout, single lab\",\n      \"pmids\": [\"22846800\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DDB2 directly interacts with LRH-1 (liver receptor homologue-1) and functions as the substrate recognition component of CUL4-DDB1 to promote LRH-1 ubiquitination and proteasomal degradation; DDB2 overexpression reduces insulin-stimulated LRH-1 levels and decreases glucokinase expression; DDB2 knockdown increases glucose uptake and intracellular glucose-6-phosphate.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assay, DDB2 overexpression/knockdown, gene expression and glucose metabolism assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, and metabolic readout, single lab\",\n      \"pmids\": [\"30923324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DDB2 is involved in ubiquitination and degradation of PAQR3; DDB2 interacts with PAQR3 in vivo and in vitro; DDB2 controls PAQR3 protein stability and polyubiquitination; Lys-61 of PAQR3 is the target site; DDB2 knockdown decreases cancer cell proliferation and migration in a PAQR3-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, in vitro interaction assay, ubiquitination assay, Lys-61 mutation, DDB2/PAQR3 double knockdown epistasis\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding, ubiquitination assay, and site-specific mutagenesis plus epistasis, single lab\",\n      \"pmids\": [\"26205499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CRL4-DDB2 is a novel E3 ubiquitin ligase for CDT2; DDB2 overexpression enhances CDT2 ubiquitination and degradation via a PIP-box-independent mechanism; DDB2 knockdown stabilizes CDT2 and arrests the cell cycle in G1; this pathway indirectly regulates CDT1 stability and pre-replication complex assembly.\",\n      \"method\": \"Co-immunoprecipitation, in vivo ubiquitination assay, DDB2 knockdown/overexpression, PIP-box mutant, cell cycle analysis\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitination assay, mutagenesis, and cell cycle readout, single lab\",\n      \"pmids\": [\"33557942\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"UVRAG localizes to photolesions, associates with DDB1, and promotes assembly and activity of the DDB2-DDB1-CUL4A-ROC1 (CRL4-DDB2) ubiquitin ligase complex, leading to efficient XPC recruitment and global genome NER; UVRAG depletion decreases substrate handover to XPC.\",\n      \"method\": \"Co-immunoprecipitation of UVRAG with DDB1, local UV irradiation immunofluorescence, UVRAG depletion with NER and XPC recruitment readout, Drosophila genetic model\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and localization assay with NER functional readout, confirmed in Drosophila model\",\n      \"pmids\": [\"27203177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Claspin physically associates with DDB1 and DDB2 and is required for UV-induced DDB2 degradation and co-localization of DDB2 to damage sites; Claspin knockdown abolishes UV-induced DDB2 turnover at damage foci but does not affect XPC levels or XPC co-localization with lesions.\",\n      \"method\": \"Claspin siRNA knockdown, DDB2 degradation assay, immunofluorescence co-localization, co-immunoprecipitation\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with multiple readouts and Co-IP, single lab\",\n      \"pmids\": [\"17196446\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"DDB2 associates with XRCC5/6 (Ku70/Ku80) in a CUL4-independent and DNA-PKcs-independent manner; in the absence of DNA damage, chromatin association of XRCC5 requires DDB2; DDB2 recruits XRCC5 to the SEMA3A gene promoter to activate its transcription; XRCC5 depletion inhibits SEMA3A expression without affecting VEGFA (a DDB2-repressed gene).\",\n      \"method\": \"Co-immunoprecipitation, chromatin fractionation, DDB2 knockdown with XRCC5 localization readout, ChIP at SEMA3A promoter\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, and loss-of-function localization assay, single lab\",\n      \"pmids\": [\"28035050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MEKK1 kinase constitutively interacts with a cytosolic CRL4 complex and is cleaved by caspases after DNA damage; MEKK1 kinase activity triggers autoubiquitination of the CRL4 complex; MEKK1 knockdown prevents DNA damage-induced degradation of DDB2 and p21; K63-linked ubiquitin chains contribute to DDB2/p21 decay and cell survival.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitin-linkage replacement strategy, MEKK1 knockdown, DDB2 degradation assay, cell survival assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ubiquitin replacement, and knockdown with degradation readout, single lab\",\n      \"pmids\": [\"34251884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DDB2 binds to the ALDH1A1 gene promoter, facilitates H3K27me3 enrichment at this region, and competes with the transcription factor C/EBPβ for binding, thereby repressing ALDH1A1 transcription and suppressing cancer stem cell dedifferentiation in ovarian cancer cells.\",\n      \"method\": \"ChIP for DDB2 and H3K27me3 at ALDH1A1 promoter, DDB2/C/EBPβ competition assay, DDB2 overexpression/knockdown with ALDH1A1 expression and CSC phenotype readout\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and competition assay with functional CSC readout, single lab\",\n      \"pmids\": [\"29752431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"DDB2 binds to an upstream promoter element in the HIF1A gene and recruits Suv39h1 to promote H3K9me3, repressing HIF1α mRNA expression in both normoxia and hypoxia; DDB2 knockdown enhances angiogenic marker expression and promotes xenograft tumor growth.\",\n      \"method\": \"ChIP for DDB2 and H3K9me3 at HIF1A promoter, DDB2 knockdown with HIF1α mRNA and angiogenic marker readout, xenograft tumor growth\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and loss-of-function with in vivo readout, single lab\",\n      \"pmids\": [\"31740787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Four DDB2 splicing variants (D1-D4) were identified in HeLa cells; D1 and D2 act as dominant negative inhibitors of DNA repair; D1/D2 are not part of the damaged DNA-protein complex (EMSA); DDB2-WT interacts with D1 via co-immunoprecipitation; D1 expression reduces DDB1 nuclear import.\",\n      \"method\": \"RT-PCR, EMSA, DNA repair assay, co-immunoprecipitation, nuclear import assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple methods establishing dominant negative mechanism, single lab\",\n      \"pmids\": [\"14751237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"DDB2 is required for nuclear accumulation of DDB1; DDB2 C-terminal deletion mutants that fail to bind DDB1 can still associate with HBx and enhance nuclear accumulation of HBx independently of DDB1 binding, revealing a DDB1-independent DDB2 function in nuclear import.\",\n      \"method\": \"DDB2 deletion mutant expression, co-immunoprecipitation, nuclear localization assay\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — deletion mutant series with nuclear localization readout, single lab\",\n      \"pmids\": [\"11581406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DDB2 levels in the cell critically determine the amount of DDB1 temporally immobilized on UV-damaged DNA; DDB2 (not CUL4A) is indispensable for DDB1 binding to damage sites; UV-induced DDB2 proteolysis releases DDB1 from continuous association with unrepaired DNA.\",\n      \"method\": \"FRAP of fluorescently tagged DDB1, DDB2 knockdown/overexpression, local UV irradiation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — FRAP with genetic manipulation of DDB2 levels, single lab\",\n      \"pmids\": [\"18936169\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Both DDB1 and DDB2 subunits must be present for UV-damaged DNA binding activity; XP-E patient-derived DDB2 mutations (L350P, ΔN349, others) abolish DDB activity when expressed in insect cells; wild-type p48 (DDB2) restores DDB activity to XP-E cell-free extracts; these mutations do not affect nuclear localization of p48.\",\n      \"method\": \"Baculovirus overexpression of individual subunits, EMSA with UV-damaged DNA, complementation of XP-E extracts\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical reconstitution with individual subunits and patient-derived mutants, functional complementation\",\n      \"pmids\": [\"10777490\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DDB2 (XPE/p48) is the substrate-recognition subunit of the CRL4(DDB2) E3 ubiquitin ligase complex that directly binds UV-induced photolesions (6-4PPs and CPDs) via its WD40 domain using a hairpin-insertion/extrusion mechanism; it opens chromatin at damage sites through PARP1-ALC1, recruits XPC for NER handover (regulated by competitive ubiquitination, deubiquitination by USP24/USP44, and post-translational modifications including poly-ADP-ribosylation, α-N-methylation, and SUMOylation), and also functions as a transcriptional regulator that represses EMT drivers, antioxidant genes, HIF1A, and ALDH1A1 while activating IκBα and RNF43, and controls cell fate after DNA damage by targeting p21 and p53 for CUL4A-mediated degradation.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DDB2 (XPE/p48) is the DNA-damage-recognition subunit of the CRL4(DDB2) E3 ubiquitin ligase that initiates global-genome nucleotide excision repair (GG-NER) of UV photolesions [#0, #18]. Its WD40 domain binds the lesion directly, inserting a hairpin into the minor groove to extrude the photodimer into a binding pocket and kink the duplex, enabling detection of helix-distorting lesions including CPDs, 6-4PPs, abasic sites, and mismatches that other surveillance proteins miss [#0, #3]. Both DDB1 and DDB2 subunits are required for damaged-DNA binding, and XP-E patient mutations abolish this activity [#49]. Within the complex DDB2 partners with DDB1, CUL4A, and Roc1 to form an active E3 ligase whose output is gated by the COP9 signalosome [#1]. DDB2 opens chromatin at damage sites by promoting PARP1-dependent poly(ADP-ribosyl)ation and recruitment of the remodeler ALC1, a chromatin-decondensation function separable from its ligase activity [#8, #9], and it then hands the lesion to XPC—DDB2 being required to recruit XPC and downstream factors (XPA) to CPD sites [#2, #18, #22]. Productive handover requires timely DDB2 turnover: CUL4A-mediated ubiquitylation of the DDB2 N-terminal tail drives its dissociation and proteasomal degradation, with p97/VCP segregating it from chromatin and TFIIH arrival stabilizing the XPC-TFIIH verification complex [#4, #12, #15, #11]. This turnover is tuned by a dense regulatory layer—XPC/centrin-2 competitive protection [#15], SIRT6 deacetylation [#13], PARsylation, α-N-methylation, SUMOylation by PIASy [#8, #14, #16, #17], and deubiquitination by USP24 and USP44 [#27, #28]. Beyond repair, DDB2 expression is induced by p53 [#7], and DDB2 in turn directs CRL4 to degrade p21 and modulate p53, governing the apoptosis-versus-arrest cell-fate decision after DNA damage [#23, #24]. DDB2 also acts as a chromatin-associated transcriptional regulator, repressing antioxidant genes, EMT drivers, HIF1A, and ALDH1A1 through recruitment of Suv39h/EZH2 and repressive histone methylation, while activating IκBα and RNF43 [#30, #31, #44, #45, #34, #32]. Inactivating DDB2 mutations underlie the xeroderma pigmentosum complementation group E (XP-E) defect in UV-damaged DNA binding and repair [#49].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Established that DDB2 is the subunit responsible for UV-damaged DNA binding and that its loss explains the XP-E repair defect, defining DDB2's core biochemical identity.\",\n      \"evidence\": \"Baculovirus reconstitution of individual subunits, EMSA with UV-damaged DNA, and complementation of XP-E extracts with patient-derived mutants\",\n      \"pmids\": [\"10777490\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how the lesion is physically engaged\", \"Did not define the larger E3 ligase context\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified CUL4A as the E3 that targets DDB2 for proteasomal degradation and showed DDB2 controls DDB1 nuclear accumulation, linking DDB2 turnover and localization to the cullin machinery.\",\n      \"evidence\": \"Coexpression, ubiquitination assays, proteasome inhibition, binding-defective XP-E mutant, and deletion-mutant nuclear localization assays\",\n      \"pmids\": [\"11564859\", \"11581406\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional purpose of DDB2 degradation during repair not yet defined\", \"DDB1-independent nuclear import role characterized only via HBx\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Showed DDB2 is a transcriptional target of p53 (with BRCA1 enhancement), placing DDB2 induction within the DNA-damage response and explaining species differences in UV-inducible expression.\",\n      \"evidence\": \"p53 promoter-binding and reporter assays, ChIP, antisense BRCA1 knockdown, and human/mouse orthologous sequence comparison\",\n      \"pmids\": [\"11971958\", \"12170778\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"BRCA1 contribution from single lab\", \"Did not address reciprocal DDB2 regulation of p53\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined DDB2 as the substrate-recognition subunit of a CUL4A-Roc1-DDB1 E3 ligase regulated by the COP9 signalosome, and showed DDB2 activates XPC recruitment to CPD lesions in cells.\",\n      \"evidence\": \"Reciprocal Co-IP, ubiquitin ligase activity assays, CSN RNAi with NER readout, and immunofluorescence in photolyase-expressing XP cells; plus DDB2-p53 mutual regulation in XP-E cells\",\n      \"pmids\": [\"12732143\", \"12944386\", \"14560002\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relevant in vivo ubiquitylation substrates at lesions not yet identified\", \"p53 reciprocal regulation supported by single lab\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Placed DDB2 downstream of p53 in driving the UV-induced chromatin redistribution of XPC, and identified dominant-negative splice variants, clarifying the DDB2-to-XPC handoff hierarchy.\",\n      \"evidence\": \"Chromatin fractionation, ectopic DDB2 rescue in p53-null cells, and RT-PCR/EMSA characterization of splice variants\",\n      \"pmids\": [\"14742321\", \"14751237\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of XPC redistribution not yet defined\", \"Physiological abundance of dominant-negative variants unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Reconstituted DDB2's lesion recognition as a structural-distortion sensor and confirmed the purified CUL4A E3 directly ubiquitylates DDB2, separating sensing from enzymatic output.\",\n      \"evidence\": \"In vitro reconstitution with purified subunits, EMSA across defined substrates, and in vitro ubiquitylation with purified E3\",\n      \"pmids\": [\"16223728\", \"15811626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specificity for genuine photolesions vs. mismatches in chromatin not resolved\", \"Functional consequence of auto-ubiquitylation not addressed here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrated that CUL4A/DDB1-mediated DDB2 degradation at damage sites is required for XPC recruitment and CPD removal, and that DDB1 is needed for CUL4A translocation but not for DDB2's intrinsic DNA binding.\",\n      \"evidence\": \"siRNA and MG132 inhibition, chromatin fractionation, micropore-irradiation immunofluorescence, CPD repair assays, plus Claspin Co-IP/knockdown\",\n      \"pmids\": [\"16527807\", \"16951172\", \"17196446\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why degradation aids handover rather than ending recognition not yet mechanistically resolved\", \"Claspin role from single lab\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Quantified DDB2 lesion-binding kinetics and showed DDB2 licenses NER by degrading p53/limiting p21, preventing p21-mediated PCNA sequestration, linking DDB2 turnover to repair competence.\",\n      \"evidence\": \"FRAP and live-cell imaging of tagged DDB2; DDB2-/- and p21-/- MEF epistasis with NER assays\",\n      \"pmids\": [\"17635991\", \"17967871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger coupling lesion residence to degradation not identified\", \"p53/p21 axis tested in mouse cells\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Provided the atomic mechanism of lesion recognition (hairpin insertion/extrusion, duplex kinking) and identified p38 MAPK as an upstream signal driving DDB2 ubiquitylation, chromatin relaxation, and repair.\",\n      \"evidence\": \"X-ray crystallography of DDB1-DDB2-DNA complexes with functional validation; p38 inhibitor with phosphorylation, ubiquitination, and CPD repair readouts; FRAP of DDB1 controlled by DDB2 levels\",\n      \"pmids\": [\"19109893\", \"18806262\", \"18936169\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"p38 phosphosite on DDB2 not mapped (Medium-confidence study)\", \"Structural model from purified components without chromatin context\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed the ligase activity is required for chromatin GG-NER and recruits XPA, with XPC/Ku oppositely tuning activity; and revealed a transcriptional repressor role at antioxidant genes via Suv39h/H3K9me3.\",\n      \"evidence\": \"In vivo ubiquitination with XP-E mutant complementation, chromatin fractionation, XPA recruitment; and ChIP/ROS/senescence assays in DDB2-deficient cells\",\n      \"pmids\": [\"20368362\", \"20351176\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Histone substrates of the ligase at lesions not fully defined\", \"Antioxidant-gene repression from single lab (Medium)\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Separated DDB2's PARP1/ALC1-driven large-scale chromatin decondensation from its ligase activity, and identified PARsylation, USP24 deubiquitination, and a p21-degradation cell-fate function as regulators of DDB2 stability and outcome.\",\n      \"evidence\": \"Chromatin-unfolding assays in DDB2-deficient cells with PARP inhibition; Co-IP/PAR assays/ALC1 depletion; USP24 yeast two-hybrid and in vitro deubiquitination; DDB2-deficient apoptosis/arrest analysis\",\n      \"pmids\": [\"22492724\", \"23045548\", \"23159851\", \"19541625\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How decondensation and ligase functions are coordinated unclear\", \"USP24 and p21 cell-fate findings from single labs (Medium)\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Expanded DDB2's regulatory repertoire to PIASy-mediated SUMOylation for CPD repair, PCNA-PIP-box-coupled degradation, checkpoint kinase (ATR/ATM) activation, and transcriptional control of EMT, NF-κB/IκBα, and NEDD4L/TGF-β.\",\n      \"evidence\": \"PIASy RNAi with lesion-specific repair; PIP-box mutagenesis and PCNA RNAi; ATR/ATM Co-IP and DDB2/XPC knockdown; EMT and IκBα/NF-κB and NEDD4L/EZH2 ChIP and functional assays\",\n      \"pmids\": [\"23860269\", \"24200966\", \"23422745\", \"23610444\", \"23774208\", \"26130719\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each regulatory and transcriptional arm rests on a single lab\", \"Direct vs. indirect transcriptional targeting not always resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified non-degradative DDB2 modifications and cofactors—α-N-trimethylation, p97/VCP segregase extraction—that govern its localization, recruitment, ATM activation, and timely chromatin removal.\",\n      \"evidence\": \"Mass spectrometry and in vitro methylation with methylation-defective mutant; p97 knockdown with DDB2/XPC epistasis, chromatin fractionation, and chromosomal aberration analysis\",\n      \"pmids\": [\"24753253\", \"24770583\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Interplay between methylation and ubiquitination not resolved\", \"Functional importance of α-N-methylation tested in one system\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the DDB2 N-terminal lysine tail as the major ubiquitination site under XPC/centrin-2 competitive protection, and extended CRL4(DDB2) substrate range to AR, PAQR3, and TGF-β regulators.\",\n      \"evidence\": \"DDB2 N-terminal mutants, in vitro competitive ubiquitination with XPC/centrin-2; Co-IP and ubiquitination assays for AR (prostate cells) and PAQR3 (epistasis), plus NEDD4L transcriptional work\",\n      \"pmids\": [\"25628365\", \"22846800\", \"26205499\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Substrate-targeting findings (AR, PAQR3) each from a single lab\", \"Physiological selectivity among the many proposed substrates unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established SUMOylation at K309 as essential for XPC recruitment and CPD repair, and identified a CUL4-independent DDB2-Ku (XRCC5/6) axis driving SEMA3A transcription.\",\n      \"evidence\": \"In vitro/in vivo SUMOylation with K309R mutant and repair readout; Co-IP, chromatin fractionation, and ChIP at the SEMA3A promoter\",\n      \"pmids\": [\"28981631\", \"28035050\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Both findings from single labs\", \"Relationship between SUMOylation and ubiquitination/degradation timing unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Broadened DDB2's transcriptional and substrate roles to HIF1A repression via Suv39h1/H3K9me3 and CRL4-mediated LRH-1 degradation affecting glucose metabolism.\",\n      \"evidence\": \"ChIP for DDB2/H3K9me3 at HIF1A with xenograft readout; Co-IP, ubiquitination, and glucose-metabolism assays for LRH-1\",\n      \"pmids\": [\"31740787\", \"30923324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each role from a single lab\", \"Direct vs. indirect mechanism for metabolic effects not fully dissected\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved the kinetic logic of repair handover—ubiquitylation-driven DDB2 dissociation enabling XPC-TFIIH verification—and added SIRT6 deacetylation and EZH2 stabilization as upstream controls of DDB2 retention.\",\n      \"evidence\": \"Live-cell imaging, FRAP, and ubiquitination manipulation; SIRT6 Co-IP/deacetylation with K35/K77 mutants; EZH2 Co-IP, ubiquitination, and cisplatin-sensitivity epistasis\",\n      \"pmids\": [\"32985517\", \"32789493\", \"32457468\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SIRT6 and EZH2 contributions from single labs (Medium)\", \"Quantitative ordering of all modifications at a single lesion not established\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified additional turnover regulators (USP44 deubiquitination, MEKK1-driven CRL4 autoubiquitination) and a new substrate (CDT2 linking DDB2 to replication licensing), extending its DNA-damage and cell-cycle roles.\",\n      \"evidence\": \"In vitro deubiquitination and USP44 KO cells/mice with tumor incidence; MEKK1 Co-IP and ubiquitin-linkage replacement; CDT2 Co-IP, ubiquitination, PIP-box mutant, and cell-cycle analysis\",\n      \"pmids\": [\"33937266\", \"34251884\", \"33557942\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"MEKK1 and CDT2 findings from single labs\", \"Integration of K63-linked chains into DDB2 fate not fully resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How DDB2's dual repair-ligase and transcriptional-regulator activities are coordinated, and which of its many proposed CRL4 substrates and transcriptional targets are physiologically dominant in a given tissue, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model relating chromatin opening, ubiquitylation, and transcriptional repression\", \"Many substrate/target relationships rest on single-lab evidence\", \"Tissue-specific selectivity of substrate engagement unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 3, 49]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 5, 18, 24]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [1, 5]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [30, 32, 34, 44, 45]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 18]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [30, 44, 45]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 47, 49]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [2, 9, 11, 22]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [10, 48]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 2, 18, 49]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 4, 5, 24]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [30, 31, 32, 34, 44, 45]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [8, 9, 30, 44, 45]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [7, 19, 29]}\n    ],\n    \"complexes\": [\n      \"CRL4(DDB2) (DDB1-DDB2-CUL4A-Roc1) E3 ubiquitin ligase\",\n      \"DDB1-DDB2 (UV-DDB) complex\"\n    ],\n    \"partners\": [\n      \"DDB1\",\n      \"CUL4A\",\n      \"XPC\",\n      \"PARP1\",\n      \"EZH2\",\n      \"USP44\",\n      \"SIRT6\",\n      \"PCNA\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":10,"faith_pct":90.0}}